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Abstract
We need to effectively combine the knowledge from surging litera-
ture with complex datasets to propose mechanistic models of
SARS-CoV-2 infection, improving data interpretation and predicting
key targets of intervention. Here, we describe a large-scale
community effort to build an open access, interoperable and
computable repository of COVID-19 molecular mechanisms. The
COVID-19 Disease Map (C19DMap) is a graphical, interactive repre-
sentation of disease-relevant molecular mechanisms linking many
knowledge sources. Notably, it is a computational resource for
graph-based analyses and disease modelling. To this end, we
established a framework of tools, platforms and guidelines neces-
sary for a multifaceted community of biocurators, domain experts,
bioinformaticians and computational biologists. The diagrams of
the C19DMap, curated from the literature, are integrated with
relevant interaction and text mining databases. We demonstrate
the application of network analysis and modelling approaches by
concrete examples to highlight new testable hypotheses. This
framework helps to find signatures of SARS-CoV-2 predisposition,
treatment response or prioritisation of drug candidates. Such an
approach may help deal with new waves of COVID-19 or similar
pandemics in the long-term perspective.
Keywords computable knowledge repository; large-scale biocuration; omics
data analysis; open access community effort; systems biomedicine
Subject Categories Computational Biology; Microbiology, Virology & Host
Pathogen Interaction
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Introduction
The coronavirus disease 2019 (COVID-19) pandemic due to severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already
resulted in the infection of over 250 million people worldwide, of
whom almost 5 million have died (https://covid19.who.int, accessed
on 05.10.2021). This global challenge motivated researchers world-
wide to an unprecedented effort towards understanding the pathology
to treat and prevent it. To date, over 170 thousand articles have been
published in relation to COVID-19 (PubMed query “covid-19[Title/
Abstract] or sars-cov-2[Title/Abstract]”, accessed on 01.07.2021).
The reportedmolecular pathophysiology that links SARS-CoV-2 infec-
tion to the clinical manifestations and course of COVID-19 is complex
and spans multiple biological pathways, cell types and organs
(Gagliardi et al, 2020). Resources such as Protein Data Bank repository
of viral protein structures (preprint: Lubin et al, 2020) or the IMEx coro-
navirus interactome (Perfetto et al, 2020) offer detailed information
about particular viral proteins and their direct binding partners.
However, the scope of this information is limited. To gain insight into
the large network of molecular mechanisms, knowledge from the vast
body of scientific literature and bioinformatic databases needs to be inte-
grated using systems biology standards. A repository of such compu-
table knowledgewill support data analysis and predictivemodelling.
With this goal in mind, we initiated a collaborative effort involv-
ing over 230 biocurators, domain experts, modellers and data
analysts from 120 institutions in 30 countries to develop the
COVID-19 Disease Map (C19DMap), an open access collection of
curated computational diagrams and models of molecular mecha-
nisms implicated in the disease (Ostaszewski et al, 2020). The
C19DMap is a constantly evolving resource, refined and updated by
ongoing biocuration, sharing and analysis efforts. Currently, it is a
collection of 42 diagrams containing 1,836 interactions between
5,499 elements, supported by 617 publications and preprints. The
summary of diagrams available in the C19DMap can be found
online (https://covid.pages.uni.lu/map_contents) and in Table EV1.
In the article, we explain the effort of our multidisciplinary
community to construct the interoperable content of the resource,
involving biocurators, domain experts and data analysts. We intro-
duce the scope of the C19DMap and the insight it brings into the
crosstalk and regulation of COVID-19-related molecular mechanisms.
Next, we outline analytical workflows that can be used on the
contents of the map, including the initial outcomes of two case stud-
ies. We conclude with a discussion on the utility and perspectives of
the C19DMap as a disease-relevant computational repository.
Results
An interoperable repository of comprehensive and
computable diagrams
We constructed a comprehensive diagrammatic description of
disease mechanisms in a way that is both human- and machine-
readable, lowering communication barriers between experimental
and computational biologists. To this end, we aligned the biocura-
tion efforts of the Disease Maps Community (Mazein et al, 2018),
Reactome (Jassal et al, 2020), and WikiPathways (Slenter et al,
2018) and developed guidelines for building and annotating these
diagrams. In addition, we integrated relevant knowledge from
public repositories (Licata et al, 2020; Perfetto et al, 2020;
Rodchenkov et al, 2020; T€urei et al, 2021) and text mining
resources to update and refine the contents of the C19DMap based
on other knowledge-building efforts. This work resulted in a series
of pathway diagrams constructed de novo, describing key events in
the COVID-19 infectious cycle and host response.
The C19DMap project involved three main groups of partici-
pants: the biocurators, the domain experts, and the analysts and
modellers. Biocurators developed a collection of systems biology
diagrams focused on the molecular mechanisms of SARS-CoV-2.
Domain experts refined the contents of the diagrams using interac-
tive visualisation and annotations. Analysts and modellers devel-
oped computational workflows to generate hypotheses and
predictions about the mechanisms encoded in the diagrams.
Figure 1 illustrates the ecosystem of the C19DMap Community,
highlighting the roles of the participants, available format conver-
sions, interoperable tools and downstream uses. The community
members and their contributions are listed on FAIRDOMHub (Wols-
tencroft et al, 2017).
Creating and accessing the diagrams
The biocurators of the C19DMap diagrams followed the guidelines
developed by the Community, WikiPathways (Slenter et al, 2018)
and Reactome (Jassal et al, 2020) based on systems biology
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standards (Le Novere et al, 2009; Demir et al, 2010; Keating et al,
2020) and persistent identifiers (Wimalaratne et al, 2018). The
diagrams are composed of biochemical reactions and interactions
(altogether called interactions) between different molecular entities
in various cellular compartments. As multiple teams worked on
related topics, biocurators reviewed other diagrams, also across
platforms (see also Materials and Methods). The diagrams are acces-
sible online and can be explored using an intuitive user interface.
Table 1 summarises information about the curated diagrams, and
Table EV1 lists the diagrams and provides links to access them.
Enrichment using knowledge from databases and text mining
The knowledge of COVID-19 mechanisms is rapidly evolving, as
shown by the growth of the COVID-19 Open Research Dataset
(CORD-19), a source of manuscripts and metadata on COVID-19-
related research (preprint: Lu Wang et al, 2020). CORD-19 currently
contains almost 480,000 articles and preprints, over ten times more
than when it was introduced more than a year ago (accessed on
05.10.2021). In such a quickly evolving environment, manual
biocuration needs to be supported by automated procedures to iden-
tify and prioritise crucial articles, molecules and their interactions to
be included in the C19DMap.
Potential knowledge sources for such assisted biocuration are
interaction and pathway databases, especially those with dedicated
COVID-19 content (Licata et al, 2020; Perfetto et al, 2020). Their
structured and annotated information on protein interactions or
causal relationships was generated using separate biocuration guide-
lines and formats. Nevertheless, their comparable identifiers and
references to source publications make them plausible building
blocks for constructing the C19DMap (see Materials and Methods).
Text mining approaches are another source of information that
can direct the biocurators towards the most recent and relevant find-
ings. They automatically extract and annotate biomolecule names
and their interactions from abstracts, full-text documents or path-
way figures (Bauch et al, 2020; Hanspers et al, 2020). Networks of
molecule interactions constructed by text mining can carry substan-
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Figure 1. Ecosystem of the COVID-19 Disease Map Community.
The main groups of the C19DMap Community are biocurators, domain experts, and analysts and modellers; communicating to refine, interpret, and apply C19DMap
diagrams. These diagrams are created and maintained by biocurators, following pathway database workflows or stand-alone diagram editors, and reviewed by domain
experts. The content is shared via pathway databases or a GitLab repository; all can be enriched by integrated resources of text mining and interaction databases. The
C19DMap diagrams are available in several layout-aware systems biology formats and integrated with external repositories, allowing a range of computational analyses,
including network analysis and Boolean, kinetic or multiscale simulations.
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Table 2 summarises open access interaction databases and text
mining knowledge bases supporting the biocuration of the
C19DMap. Molecular interactions from these sources have a broad
coverage at the cost of depth of mechanistic representation. The
biocurators used this content to build and update the map by
manual exploration or by programmatic comparison. First, the
biocurators visually explored the contents of such networks using
available search interfaces to identify interactions of interesting
molecules and encoded them in the diagrams. This task was
supported by a dedicated visualisation tool COVIDminer (https://
rupertoverall.net/covidminer). The biocurators also used assistant
chatbots that respond to natural language queries and return
Table 1. COVID-19 Disease Map contents.
Source
Individual diagrams Reactome WikiPathways




















Exploration The MINERVA Platform










Diagram Editors CellDesigner (Matsuoka et al, 2014),
Newtd, SBGN-ED (Czauderna et al,
2010), yEd+ySBGNe
Reactome pathway editorb PathVisio
(Kutmon et al, 2015)
Formats CellDesigner SBML
SBGNML (Bergmann et al, 2020)
Internal, SBML and SBGNML compliant GPML (Kutmon et al, 2015)
The table summarises biocuration resources and content of the C19DMap across three main parts of the repository. All diagrams are listed in Table EV1, and






Table 2. Resources supporting biocuration of the COVID-19 Disease Map.
Resource Type Manually curated Directed Layout COVID-19 specific
IMEx Consortium (Orchard et al, 2012) Interaction database Yes No No Yesa
SIGNOR 2.0 (Licata et al, 2020) Yes Yes Yes Yesb
OmniPath (T€urei et al, 2016) No Yes No No
Elsevier Pathway Collectionc Pathway Yes Yes Yes Yesd
INDRA (Gyori et al, 2017) Text mining Yes Yes No Yese
BioKBf No Yes No Yes
AILANI COVID-19g No Yes No Yes
OpenNLP+GNormPlush No Yes No Yes









4 of 22 Molecular Systems Biology 17: e10387 | 2021 ª 2021 The Authors
Molecular Systems Biology Marek Ostaszewski et al
meaningful answers extracted from text mining platforms. Second,
we developed routines for programmatic queries of the interaction
databases, providing automated and reproducible exploration of the
selected databases. This was realised using data endpoints: Applica-
tion programming interfaces (API) for INDRA, AILANI or Pathway
Studio, and SPARQL for BioKB. This automated exploration
retrieved functions, interactions, pathways or drugs associated with
submitted queries, e.g. gene lists. This way, otherwise time-
consuming tasks such as an assessment of completeness of a given
diagram or search for new literature evidence were automated.
Section “Exploration of the networked knowledge” describes an
application of such automated queries in crosstalk analysis.
Interoperability of the diagrams and annotations
The biocuration of the C19DMap diagrams was distributed across
multiple teams, using varying tools and associated systems biology
representations. This required a common approach to annotations
of diagram elements and their interactions. Additionally, to compare
and combine the diagrams in the C19DMap, interoperability of
layout-aware formats was needed.
The diagrams were encoded in three layout-aware formats for
standardised representation of molecular interactions: SBML,
SBGNML and GPML. All three formats, centred around molecular
interactions, provided a constrained vocabulary to encode element
and interaction types, encode layout of corresponding diagrams and
support stable identifiers for diagram components. These shared
properties, supported by a common ontology (Courtot et al, 2011),
allowed cross-format translation of the diagrams, which was essen-
tial for harmonising the effort between biocuration platforms.
The ecosystem of tools and resources supporting the C19DMap
(see Fig 1) ensured interoperability between SBML, SBGNML and
GPML via translation, preserving the diagram layout (Bohler et al,
2016; Balaur et al, 2020; Hoksza et al, 2020) for harmonised visuali-
sation of diagrams. Additionally, these diagrams were transformed
into inputs of computational pipelines and data repositories, allow-
ing network analysis, pathway modelling and interoperability with
molecular interaction repositories (Pillich et al, 2017) (see Materials
and Methods).
Structure and scope of the COVID-19 Disease Map
The C19DMap was built bottom-up, exploiting a rich bioinformatics
framework discussed in Section “An interoperable repository of
comprehensive and computable diagrams” of the Results, based on
knowledge from existing studies of other coronaviruses (Fung &
Liu, 2019) and contextualised with data emerging from studies of
SARS-CoV-2 (Gordon et al, 2020). The contents of the C19DMap are
available online, summarised in a constantly updated overview at
https://covid.pages.uni.lu/map_contents (see also Table EV1).
Currently, the C19DMap focuses on molecular processes involved in
SARS-CoV-2 entry and replication and host–virus interactions (see









































































Figure 2. The structure and content of the COVID-19 Disease Map.
An overview of the areas of focus of the C19DMap biocuration. Go to covid19map.elixir-luxembourg.org for an interactive version. Full list of diagrams and browsing
instructions are available online at covid.pages.uni.lu/map_contents.
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response, cell and organ specificity will be incorporated into the
next versions in accordance with our curation roadmap (https://
fairdomhub.org/documents/907).
While the interactions of SARS-CoV-2 with various host cell types
are vital determinants of COVID-19 pathology (Hui et al, 2020;
Mason, 2020; Ziegler et al, 2020), the current C19DMap represents
an infection of a generic host cell. Several pathways included in the
map are shared between different cell types; for example, the IFN-1
pathway is active in dendritic and lung epithelial cells and in alveo-
lar macrophages (Hadjadj et al, 2020; Lee & Shin, 2020; Sa Ribero
et al, 2020). Continued annotations of emerging expression datasets
(Delorey et al, 2021) and other sources of information will allow the
construction of cell-specific versions of the C19DMap to provide an
integrated view of the effects of SARS-CoV-2 on the human organ-
ism. An example workflow to construct such a focused version of
the map was proposed in Section “Case study: analysis of cell-
specific mechanisms using single-cell expression data”.
SARS-CoV-2 infection and COVID-19 progression are sequential
events that start with viral attachment and entry (Fig 3). These
events involve various dynamic processes and different timescales
that are not captured in static representations of pathways. The
correlation of symptoms and potential drugs suggested to date helps
downstream data exploration and drug target interpretation in the
context of therapeutic interventions.
Contents of the COVID-19 Disease Map
Virus replication cycle
The virus replication cycle includes binding of the spike surface
glycoprotein (S) to angiotensin-converting enzyme 2 (ACE2) facili-






Figure 3. Overview of the C19DMap in the context of COVID-19 progression.
The figure summarises the main sections and content of the C19DMap by illustrating the progressive but overlapping mechanisms at different levels and study features
of the disease intended as quick references for the map.
A Cellular level (light yellow), the immune response (blue) and other systemic responses (red) of the host following SARS-CoV-2 infection.
B The progression of pathophysiology from tissue damage to organ damage and multiple organ dysfunction in severe cases.
C Clinical manifestations, depending on the severity of the infection from asymptomatic to critical COVID-19.
D Potential intervention strategies that may be suggested based on the analysis of the C19DMap before, during and after infection, depending on the type and target of
the intervention.
E Clinical outcomes of SARS-CoV-2 infection. ARDS, acute respiratory distress syndrome. RAAS, renin–angiotensin–aldosterone system. SIRS, systemic inflammatory
response syndrome. For the literature on clinical manifestations, see Lauer et al, 2020; He et al, 2020; Huang et al, 2020; Bajema et al, 2020; preprint: Chen et al,
2020b; Wang et al, 2020a; Tong et al, 2020.
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other receptors (preprint: Amraei et al, 2020; preprint: Gao et al,
2020). Viral entry occurs either by direct fusion of the virion with
the cell membranes or by endocytosis (Hoffmann et al, 2020a; Xia
et al, 2020) of the virion membrane and the subsequent injection of
the nucleocapsid into the cytoplasm. Within the host cell, the
C19DMap depicts how SARS-CoV-2 hijacks the rough endoplasmic
reticulum (RER)-linked host translational machinery for its replica-
tion (Chen et al, 2010; Angelini et al, 2013; Nakagawa et al, 2016;
V’kovski et al, 2019). The RER-attached translation machinery
produces structural proteins, which, together with the newly gener-
ated viral RNA, are assembled into new virions and released to the
extracellular space via smooth-walled vesicles (Nakagawa et al,
2016) or hijacked lysosomes (Ghosh et al, 2020).
These mechanisms are illustrated in the diagrams of the “Virus repli-
cation cycle” section in Table EV1: “Attachment and entry”, “Transcrip-
tion, translation and replication” and “Assembly and release”.
Viral subversion of host defence
Endoplasmic reticulum (ER) stress results from the production of
large amounts of viral proteins that create an overload of unfolded
proteins (Kr€ahling et al, 2009; DeDiego et al, 2011; Fukushi et al,
2012). The mechanisms of the unfolded protein response (UPR)
include the mitigation of the misfolded protein load by reduced
protein synthesis and increased protein degradation (Sureda et al,
2020) through the ubiquitin–proteasome system (UPS) and autop-
hagy (Choi et al, 2018; Bello-Perez et al, 2020). SARS-CoV-2 may
perturb the process of UPS-based protein degradation via the inter-
action of the viral Orf10 protein with the Cul2 ubiquitin ligase
complex and its putative substrates (Gordon et al, 2020; Zhang
et al, 2020). The involvement of SARS-CoV-2 in autophagy is less
documented (Yang & Shen, 2020).
The increased burden of misfolded proteins due to viral replica-
tion and subversion of mitigation mechanisms may trigger
programmed cell death (apoptosis). The C19DMap encodes major
signalling pathways triggering this final form of cellular defence
against viral replication (Diemer et al, 2010). Many viruses block or
delay cell death by expressing anti-apoptotic proteins to maximise
the production of viral progeny (Kanzawa et al, 2006; Liu et al,
2007) or induce it in selected cell types (Diemer et al, 2010; Chu
et al, 2016; preprint: Chen et al, 2020b).
These mechanisms are illustrated in the diagrams of the “Viral
subversion of host defence” section in Table EV1: “ER stress and
unfolded protein response”, “Autophagy and protein degradation”
and “Apoptosis”.
Host integrative stress response
Severe acute respiratory syndrome coronavirus 2 infection damages
the epithelium and the pulmonary capillary vascular endothelium
(Bao et al, 2020), impairing respiration and leading to acute respira-
tory distress syndrome (ARDS) in severe forms of COVID-19 (Huang
et al, 2020). The release of pro-inflammatory cytokines and hyper-
inflammation are known complications, causing further widespread
damage (Chen et al, 2020a; Lucas et al, 2020). Coagulation distur-
bances and thrombosis are associated with severe cases, but specific
mechanisms have not been described yet (Iba et al, 2020; Klok et al,
2020). Nevertheless, it was shown that SARS-CoV-2 disrupts the
coagulation cascade and causes renin–angiotensin system (RAS)
imbalance (Magro et al, 2020; Urwyler et al, 2020).
Angiotensin-converting enzyme 2, used by SARS-CoV-2 for host
cell entry, is a regulator of RAS and is widely expressed in the
affected organs. The diagrams in the repository describe how ACE2-
converted angiotensins trigger the counter-regulatory arms of RAS
and the downstream signalling via AGTR1, regulating the coagula-
tion cascade (Gheblawi et al, 2020; McFadyen et al, 2020).
These mechanisms are illustrated in the diagrams of the “Integra-
tive stress response” section in Table EV1: “Renin–angiotensin
system” and “Coagulopathy”.
Host immune response
The innate immune system detects specific pathogen-associated
molecular patterns, through pattern recognition receptors (PRRs)
that recognise viral RNA in the endosome during endocytosis or in
the cytoplasm during virus replication. The PRRs activate associated
transcription factors promoting the production of antiviral proteins
such as interferon-alpha, interferon-beta and interferon-lambda
(Takeuchi & Akira, 2010; Berthelot & Liote, 2020; Blanco-Melo et al,
2020; Hadjadj et al, 2020; Park & Iwasaki, 2020). SARS-CoV-2
impairs this mechanism (Chu et al, 2020), but the exact components
are yet to be elucidated (Liao et al, 2005; Devaraj et al, 2007; Frie-
man et al, 2007; Li et al, 2016; Bastard et al, 2020). The C19DMap
includes both the virus recognition process and the viral evasion
mechanisms. It provides the connection between virus entry, its
replication cycle, and the effector pathways of pro-inflammatory
cytokines, especially of the interferon type I cascade (Wong et al,
2018; Mesev et al, 2019; Mantlo et al, 2020; Su & Jiang, 2020;
Thoms et al, 2020; Ziegler et al, 2020).
Key metabolic pathways modulate the availability of nutrients
and critical metabolites of the immune microenvironment (Rao
et al, 2019). They are a target of infectious agents that reprogram
host metabolism to create favourable conditions for their reproduc-
tion (Kedia-Mehta & Finlay, 2019). The C19DMap encodes several
immunometabolic pathways and provides detailed information
about the way SARS-CoV-2 proteins interact with them. The meta-
bolic pathways include haem catabolism (Batra et al, 2020) and its
downstream target, the NLRP3 inflammasome (van den Berg & Te
Velde, 2020), tryptophan-kynurenine metabolism governing the
response to inflammatory cytokines (Murakami et al, 2013;
preprint: Su et al, 2020), and nicotinamide and purine metabolism
(Renz et al, 2020). Finally, we represent the pyrimidine synthesis
pathway, tightly linked to purine metabolism, affecting viral DNA
and RNA syntheses (Hayek et al, 2020; Xiong et al, 2020).
These mechanisms are illustrated in the diagrams of the “Innate
Immune Response” section in Table EV1: “PAMP signalling”,
“Induction of interferons and the cytokine storm” and “Altered host
metabolism”.
Exploration of the networked knowledge
The diagrams of the C19DMap were curated in a distributed manner
across various platforms and tools. In order to coordinate such an
effort and get a systematic overview of the contents of the map, we
programmatically analysed the content of the diagrams, benefiting
from their standard encoding and annotation (see Materials and
Methods). This allowed us to identify crosstalk and functional over-
laps across pathways. Then, we linked the diagrams to interaction
and text mining databases to fill the gaps in our understanding of
COVID-19 mechanisms and generate new testable hypotheses.
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Below, we discuss three specific examples of exploration of this
networked knowledge (see Fig 4). Access to the complete content of
the crosstalk diagrams can be found in Materials and Methods.
Existing crosstalk between COVID-19 Disease Map diagrams
First, the existing pathways crosstalk emerged by matching entities
between the diagrams (Figs 4A, EV1 and EV2). For instance, they
link different pathways involved in type I IFN (IFN-1) signalling.
Responses to RNA viruses and pathogen-associated molecular
patterns (PAMPs) share common pathways, involving RIG-I/Mda-5,
TBK1/IKKE and TLR signalling, leading to the production of IFN-1s,
especially IFN-beta (H€acker & Karin, 2006) and IFN-alpha
(Mogensen, 2009). Downstream, IFN-1 activates Tyk2 and Jak1
protein tyrosine kinases, causing STAT1:STAT2:IRF9 (ISGF3)
complex formation to promote the transcription of IFN-stimulated
genes (ISGs). Importantly, TBK1 also phosphorylates IKBA, an NF-
kB inhibitor, for proteasomal degradation in crosstalk with the UPS
pathway, allowing free NF-kB and IRF3 to co-activate ISGs (Fang
et al, 2017). Another TBK1 activator, STING, links IFN signalling
with pyrimidine metabolism.
SARS-CoV-2 M protein affects these IFN responses by inhibiting
the RIG-I:MAVS:TRAF3 complex and TBK1, preventing IRF3 phos-
phorylation, nuclear translocation and activation (Zheng et al,
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Nodes with 1 or 2 neighbours
3 or 4 neighbours
5 or more neighbours
Diagrams or diagram groups 
in the COVID-19 Disease Map
Nodes suggested as novel regulators
Interactions (undirected) connecting elements and diagrams or diagram groups 
in the COVID-19 Disease Map, in which they participate 
Novel interactions (directed) suggested by text mining and interaction databases 
Figure 4. Exploration of the existing and candidate crosstalk between the diagrams of the COVID-19 Disease Map.
The network structure of the diagrams and their interactions based on existing crosstalk (shared elements), candidate crosstalk, and candidate regulators. Colour code:
green—pathways or pathway groups; blue—proteins with one or two neighbours; yellow—proteins with three or four neighbours; and red—proteins with five or more
neighbours. Candidate molecular interactions are shown as directed edges. Candidate regulator elements are marked with a solid black border. See Materials and
Methods for details.
A Existing crosstalk between individual diagrams of IFN-I and RELA-related mechanisms.
B Candidate crosstalk between pathway groups.
C Candidate regulators of existing diagrams from text mining and interaction databases.
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associated with impaired IFN-1 (Hadjadj et al, 2020) may be a host
attempt to compensate for the lack of IFN-1 activation (Rubio et al,
2013), leading to NF-kB hyperactivation and release of pro-
inflammatory cytokines. Also, SARS-CoV-1 viral papain-like proteases,
contained within the nsp3 and nsp16 proteins, inhibit STING and its
downstream IFN secretion (Chen et al, 2014). Perturbations in these
pathways may impair the IFN response against SARS-CoV-2 and
explain persistent blood viral load and an exacerbated inflammatory
response in COVID-19 patients (Hadjadj et al, 2020).
New crosstalk from interaction and text mining datasets
New relationships emerging from associated interaction and text
mining databases (see Section “Exploration of the networked
knowledge” of the Results) suggested new pathway crosstalk (see
Figs 4B and EV3). One of these was the interplay between ER stress
and the immune pathways, as PPP1R15A regulates the expression
of TNF and the translational inhibition of both IFN-1 and IL-6
(Smith, 2018). This finding coincided with the proposed interaction
of pathways responsible for protein degradation and viral detection,
as SQSTM1, an autophagy receptor and NFKB1 regulator, controls
the activity of cGAS, a double-stranded DNA detector (Seo et al,
2018). Another association revealed by text mining data was
ADAM17 and TNF release from the immune cells in response to
ACE2-S protein interaction with SARS-CoV-1 (Haga et al, 2008),
potentially increasing the risk of COVID-19 infection (Zipeto et al,
2020). This new interaction connected diagrams of the (i) “Viral
replication cycle” via ACE2-S protein interactions, (ii) “Viral subver-
sion of host defence mechanisms” via ER stress, (iii) “Host
integrative stress response” via the renin–angiotensin system and
(iv) “Host innate immune response” via pathways implicating TNF
signalling.
Novel regulators of protein activity
Finally, we identified potential novel regulators of proteins in the
C19DMap using interaction and text mining databases (see Fig 4C).
These proteins take no part in the current version of the map but
interact with molecules already represented in at least one of the
diagrams. An example of such a novel regulator was NFE2L2, which
controls the activity of HMOX1 in the context of viral infection
(Kesic et al, 2011). In turn, HMOX1 controls immunomodulatory
haem metabolism (Zhang et al, 2019), the mechanisms of viral
replication, and is a target of SARS-CoV-2 Orf3a protein (Miao et al,
2020). The suggested NFE2L2-HMOX1 interaction is supported by
the literature reports of NFE2L2 importance in COVID-19 cardiovas-
cular complications due to crosstalk with the renin–angiotensin
signalling pathway (Valencia et al, 2020) and potential interactions
with viral entry mechanisms (Hassan et al, 2020). Interestingly, the
modulation of the NFE2L2-HMOX1 axis was already proposed as a
therapeutic measure for inflammatory diseases (Attucks et al,
2014), making it an appealing extension of the C19DMap.
Computational analysis and modelling for hypothesis generation
The standardised representation and programmatic access to the
contents of the C19DMap support reproducible analytical and
modelling workflows. Here, we discuss the range of possible
Table 3. Examples of computational workflows using the COVID-19 Disease Map
Workflow
COVID-19 Disease
Map contents User input Tools Output
Data interpretation Online diagrams Transcriptomics, Proteomics,
Metabolomics
The MINERVA Platform
(Gawron et al, 2016)
PathVisio (Kutmon et al, 2015)









transcription factors activity under
SARS-CoV-2 infectionb





(Messina et al, 2020)
Identification of new SARS-CoV-2-
relevant interactions
Mechanistic modelling Diagrams in SIF format
(via CasQ)
TranscriptomicsMetabolomics HiPATHIA (Salavert et al, 2016)
CARNIVAL (Liu et al, 2019)
Endpoint predictionc
Drug target effect prediction





(Helikar et al, 2012)











PhysiBoSS (Letort et al, 2019):
MaBoSS (Stoll et al, 2017)
+ PhysiCell





Each workflow relies on the input from the C19DMap, either a direct diagram or its transformed contents, available in the GitLab repository. The workflow users
may supply omics datasets to interpret them in the context of the map or test their hypotheses about how disease models will behave under specific
perturbations.
aExample: see Results, Case study—analysis of cell-specific mechanisms using single-cell expression data.
bExample: see Results, Case study—RNA-Seq-based analysis of transcription factor activity.
cExample: see Results, Case study—RNA-Seq-based analysis of pathway signalling.
dhttps://colomoto.github.io/colomoto-docker/
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approaches and demonstrate preliminary results, focusing on inter-
operability, reproducibility and applicability of the methods and
tools. Table 3 summarises selected computational workflows that
can support data interpretation and hypothesis testing in COVID-19
research.
Data interpretation and network analysis
The projection of omics data onto the C19DMap broadens and deep-
ens our understanding of disease-specific mechanisms, in contrast
to classical pathway enrichment analyses, which often produce lists
of generic biological mechanisms. Visualisation of omics datasets on
the map diagrams creates overlays, allowing interpretation of speci-
fic conditions, such as disease severity or cell types (Satagopam
et al, 2016).
Datasets projected on the C19DMap can create signatures of
molecular regulation determined by the expression levels of the corre-
sponding molecules. Together, multiple omics readouts and multiple
measurements can increase the robustness of such signatures (De
Meulder et al, 2018). This interpretation can be extended using avail-
able SARS-CoV-2-related omics and interaction datasets (Bouhaddou
et al, 2020) to infer which transcription factors, their target genes and
signalling pathways are affected upon infection (Dugourd & Saez-
Rodriguez, 2019). Combining regulatory interactions of the C19DMap
with such data collections extends the scope of the analysis and may
suggest new mechanisms to include in the map.
Besides the visual exploration of omics datasets, the network
structure of the C19DMap allows extended network analysis of
viral–human protein–protein interactions (PPIs) (Gordon et al,
2020). It can be expanded by merging virus–host with human PPIs
and proteomics data to discover clusters of interactions indicating
human biological processes affected by the virus (Messina et al,
2020). These clusters can be interpreted by visualising them on the
C19DMap diagrams to reveal additional pathways or interactions to
add to the map.
Mechanistic and dynamic computational modelling
Diagrams from the C19DMap can be coupled with omics datasets to
estimate their functional profiles and predict the effect of interven-
tions, e.g. effects of drugs on their targets (Salavert et al, 2016).
However, such an approach has a substantial computational
complexity, limiting the size of the input diagrams. Large-scale
mechanistic pathway modelling can address this challenge but
requires transformation of diagrams into causal networks, which,
combined with transcriptomics, (phospho-)proteomics or metabolo-
mics data (Dugourd et al, 2021), contextualise the networks and
hypotheses about intervention outcomes. Both approaches provide
a set of coherent causal links connecting upstream drivers such as
stimulations or pathogenic mutations to downstream changes in
diagram endpoints or transcription factor activities.
Dynamic modelling allows analysis of changes of molecular
networks in time to understand their complexity under disease-
related perturbations (Naldi et al, 2018b). C19DMap diagrams, trans-
lated to SBML qual using CaSQ (see Materials and Methods), can be
used in discrete modelling, using modelling software that supports
SBML qual file import. Notably, multiscale processes involved in viral
infection, from molecular interactions to multicellular behaviour, can
be simulated using a dedicated computational architecture. In such a
multiscale setup, single-cell models run in parallel to capture the
behaviour of heterogeneous cell populations and their intercellular
communications at different time scales, e.g. diffusion, cell mechan-
ics, cell cycle, or signal transduction (Osborne et al, 2017; preprint:
Wang et al, 2020). Implementing detailed COVID-19 signalling
models in the PhysiBoSS framework (Letort et al, 2019) may help
better understand complex dynamics of interactions between immune
system components and the host cell.
Case study: analysis of cell-specific mechanisms using single-cell
expression data
To investigate cell-specific mechanisms of COVID-19, we projected
single-cell expression data onto the C19DMap. To this end, we calcu-
lated differentially expressed genes (DEGs) for two datasets relevant
to the disease. The first dataset describes non-infected bronchial
secretory cells (Lukassen et al, 2020; Data ref: Lukassen et al, 2020),
where we selected DEGs from three different subtypes of secretory
cells dubbed (i) secretory1, (ii) secretory2 and (iii) secretory3 (tran-
sient) cells. The second dataset describes SARS-CoV-2-infected intesti-
nal organoids (Triana et al, 2021; Data ref: Triana et al, 2021), where
we selected DEGs from (iv) infected and (v) bystander immature
enterocytes from the intestinal organoids infected with SARS-CoV-2.
DEGs (i), (ii) and (iii) can serve as an illustration of pathway activity
across normal lung cells, while datasets (iv) and (v) demonstrate a
comparison of molecular activity in cells of infected intestinal tissue.
These selected datasets are available as overlays in the C19DMap and
can be interactively explored, showing cell-type-specific dysregulation
of particular diagrams (see Materials and Methods).
Visual exploration of the differential expression profiles in the
C19DMap revealed that transient secretory cells specifically express
molecules associated with the virus replication cycle (TMPRSS2).
This suggests that these cells are more susceptible to viral entry than
the other types of bronchial secretory cells. Also, the interferon 1
signalling pathway was up-regulated in both secretory1 and tran-
sient secretory cells. However, transient secretory cells showed up-
regulation of elements up- and downstream of the pathway
(IFNAR1-JAK1, and ISG15 or OAS1); in secretory1 cells, the up-
regulated proteins were downstream (transcription factor AP-1). In
the intestinal organoid dataset, the comparison of infected and
bystander immature enterocytes confirmed the downregulation of
the ACE2 receptor reported by the original article (Triana et al,
2021; Data ref: Triana et al, 2021), as visualised in the virus replica-
tion cycle diagram. In addition, exploration of other affected path-
ways may suggest the context of this observation – for instance, the
C19DMap demonstrated the differential activity of the pyrimidine
deprivation pathway, which could suggest a reduction of transcrip-
tional activity as a host response to the viral infection. Enrichment
analysis of diagrams indicated that mitochondrial dysfunction,
apoptosis, and inflammasome activation were dysregulated in
infected enterocytes. The enrichment analysis of the cell-type-
specific overlays was obtained by the GSEA plugin of the C19DMap.
These results can be replicated and examined directly by the users
via the visual interface of the C19DMap (see https://covid.pages.
uni.lu/minerva-guide/ and Materials and Methods).
Case study: RNA-Seq-based analysis of transcription factor
activity
As discussed above, the diagrams of the C19DMap can be coupled
with omics datasets. Here, we highlight how the map systematically
10 of 22 Molecular Systems Biology 17: e10387 | 2021 ª 2021 The Authors
Molecular Systems Biology Marek Ostaszewski et al
reveals the transcription factors (TFs) related to SARS-CoV-2 infec-
tion. To do so, we conducted differential expression analysis
between SARS-CoV-2 infected Calu-3 human lung adenocarcinoma
cell line and controls. Results were used to estimate TF activity
deregulation upon viral infection. We mapped the outcomes of the
TF activities to pathway diagrams of the C19DMap (see Materials
and Methods).
The results for the interferon type I signalling diagram are
shown in Fig 5. This pathway included some of the most active
TFs after SARS-CoV-2 infection, such as STAT1, STAT2, IRF9 and
NFKB1. These are well-known components of cytokine signalling
and antiviral responses (Cheon et al, 2013; Fink & Grandvaux,
2013). Interestingly, these TFs were located downstream of various
viral proteins (E, S, Nsp1, Orf7a and Orf3a) and members of the
MAPK pathway (MAPK8, MAPK14 and MAP3K7). SARS-CoV-2
infection is known to promote MAPK activation, which mediates
the cellular response to pathogenic infection and promotes the
production of pro-inflammatory cytokines (Bouhaddou et al,
2020). Overall, these results highlighted that the molecular mecha-
nisms of the response of the human cells to SARS-CoV-2 infection
can be investigated by combining omics datasets with the diagrams
of the C19DMap.
Case study: RNA-Seq-based analysis of pathway signalling
The diagrams of the C19DMap allow for a complex analysis of how
the infection may affect signalling sequences in encoded pathways
based on available omics data. To demonstrate this approach, we
applied a mechanistic modelling algorithm that estimates the func-
tional profiles of signalling circuits in the context of omics datasets.
We used expression profiles from nasopharyngeal swabs of COVID-
19 patients and controls (Lieberman et al, 2020; Data ref: Lieberman
et al, 2020) to calculate the differential expression profiles and
derive the pathway signalling activities (see Materials and Meth-
ods).
To illustrate this approach, we focused on the results of the anal-
ysis of the apoptosis pathway, also shown in Fig 6 and Table EV2.
We observed an overall downregulation of both the CASP3 and
CASP7 subpathways and an inhibition of the circuit ending in
effector protein CASP3, possibly due to the downregulation of AKT1
and BAD and the downstream inhibition of BAX. Although the BAX
downstream genes were up-regulated, the signal arriving at them
was diminished by the effect of the previous nodes. Although CASP8
was up-regulated, the cumulative effect of the individual node activ-
ities resulted in the inhibition of CASP7. Indeed, inflammatory
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Figure 5. Interferon type I signalling pathway diagram of the COVID-19 Disease Map integrated with TF activity derived from transcriptomics data after SARS-
CoV-2 infection.
A zoom was applied in the area containing the most active TFs (red nodes) after infection. Node shapes: host genes (rectangles), host molecular complex (octagons), viral
proteins (V shape), drugs (diamonds) and phenotypes (triangles).
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infection (Li et al, 2020), and the role of caspase-induced apoptosis
has been established, together with the ripoptosome/caspase-8
complex, as a pro-inflammatory checkpoint (Chauhan et al, 2018),
which may be triggering up-regulation of such processes in other
pathways. Overall, our findings recapitulate reported outcomes and
provide explanations of the effects of interactions on pathway
elements.
Discussion
Our knowledge of COVID-19 molecular mechanisms is growing at
a great speed, fuelled by global research efforts to investigate the
pathophysiology of SARS-CoV-2 infection. Keeping an overview
of all the findings, many of which focus on individual molecules,
is a great challenge just one year after the start of the pandemic.
The C19DMap aggregates this knowledge into molecular interac-
tion diagrams, making it available for visual exploration by life
science and clinical researchers and analysis by computational
biologists.
The map complements and interfaces with other COVID-19
resources such as interaction databases (Licata et al, 2020; Perfetto
et al, 2020), protein-centric resources (preprint: Lubin et al, 2020)
and relevant omics data repositories (Delorey et al, 2021) by provid-
ing a context to particular pieces of information and helping with
data interpretation. The diagrams of the C19DMap describe molecu-
lar mechanisms of COVID-19, grounded in the relevant published
SARS-CoV-2 research, completed where necessary by mechanisms
discovered in related beta-coronaviruses.
We developed the contents of the C19DMap de novo in an
unprecedented, community-driven effort involving independent
biocurators, as well as WikiPathway and Reactome biocurators.
Over forty diagrams with molecular resolution have been
constructed since March 2020, shared across three platforms. In this
work, we combined and harmonised expertise in biocuration across
multiple teams, formulated clear guidelines and cross-reviewed the
outcomes of our work with domain experts. Although the approach
of community curation was applied in the past (Slayden et al, 2013;
Naithani et al, 2019), we are not aware of any curation effort on a
similar scale for a single human disease to date.
In this work, we established a computational framework accom-
panying the biocuration process, integrating interaction databases
and text mining solutions to accelerate diagram building. This
allowed us not only to enrich particular diagrams but also to
explore crosstalk between them and prioritise key novel regulators
of the encoded pathways. Thanks to the interoperability of dif-
ferent systems biology formats, we performed this analysis for
diagrams constructed in different biocuration environments,
extending current advances in pathway interoperability (Bohler
et al, 2016).
Figure 6. Representation of the activation levels of apoptosis pathway in nasopharyngeal swabs from SARS-CoV-2-infected individuals.
Activation levels were calculated using transcriptional data from GSE152075 and the Hipathia mechanistic pathway analysis algorithm. Each node represents a gene
(ellipse), a human metabolite/viral protein (circle) or a function (rectangle). The pathway is composed of circuits from a receptor to an effector. Significant differential
regulation of circuits in infected cells is highlighted by colour arrows (blue: inactive in infected cells). The colour of elements corresponds to the level of differential
expression in SARS-CoV-2-infected human nasopharyngeal swabs versus non-infected nasopharyngeal human swabs. Blue: downregulated, red: up-regulated and white:
no statistically significant differential expression.
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Moreover, by developing reproducible analysis pipelines for the
contents of the C19DMap, we promoted early harmonisation of
formats, support of standards and transparency in all steps. Prelimi-
nary results of such efforts are illustrated in the case studies above.
Notably, the biocurators and domain experts participated in the
analysis helped to evaluate the outcomes and corrected the curated
content if necessary. This way, we improve the quality of the analy-
sis and increase the reliability of the models used to generate
testable predictions.
The C19DMap is an open access repository of diagrams and
reproducible workflows for content conversion and analysis. We
followed FAIR principles in making our content and code available
to the entire research community (Wilkinson et al, 2016). Impor-
tantly, FAIRDOMHub is an essential platform for disseminating all
information about the project and linking contributors to their
contributions. The C19DMap Community is open and expanding as
more people with complementary expertise join forces. Using the
FAIR approach for sharing the results of our work makes this effort
more scalable. Recognising individual contributions and open
access policy promote the distributed knowledge building and
generation of research data.
The project aims to provide the tools to deepen our understand-
ing of the mechanisms driving the infection and help boost drug
development supported by testable suggestions. It offers insights
into the dynamic nature of the disease at the molecular level and its
propagation at the systemic level. Thus, it provides a platform for a
precise formulation of models, accurate data interpretation, the
potential for disease mitigation and drug repurposing. In the longer
run, the constantly growing C19DMap content will be used to facili-
tate the finding of robust signatures related to SARS-CoV-2 infection
predisposition, disease evolution or response to various treatments,
along with the prioritisation of new potential drug targets or drug
candidates.
This approach to an emerging worldwide pandemic leveraged
the capacity and expertise of an entire swath of the bioinformatics
community, bringing them together to improve the way we build
and share knowledge. By aligning our efforts, we strive to provide
COVID-19-specific pathway models, synchronise content with simi-
lar resources and encourage discussion and feedback at every stage
of the curation process. Such an approach may help to deal with
new waves of COVID-19 or similar pandemics in the long-term
perspective.
Materials and Methods
Reagents and Tools table
Reagent/Resource Reference or Source Identifier or Catalog Number
Software
CellDesigner v4.4.2 http://www.celldesigner.org (Matsuoka et al, 2014)
Newt v3.0 https://newteditor.org
SBGN-ED Czauderna et al (2010)
ySBGN https://github.com/sbgn/ySBGN
The MINERVA Platform v15.1.4 https://minerva-web.lcsb.uni.lu (Gawron et al, 2016)
Reactome https://reactome.org (Jassal et al, 2020)
WikiPathways https://www.wikipathways.org (Slenter et al, 2018)
PathVisio v3.3.0 https://pathvisio.github.io (Kutmon et al, 2015)
INDRA Gyori et al (2017)
AILANI COVID-19 https://ailani.ai
BioKB https://biokb.lcsb.uni.lu/topic/DOID:0080599
OpenNLP + GNormPlus https://opennlp.apache.org/ (Wei et al, 2015)
COVIDminer https://rupertoverall.net/covidminer
rWikipathways v 1.12 10.18129/B9.bioc.rWikiPathways
OmniPathR https://github.com/saezlab/OmnipathR
The MINERVA Conversion API v15.1 https://minerva.pages.uni.lu/doc/api/15.1/converter/ (Hoksza et al, 2020)
cd2sbgml https://github.com/sbgn/cd2sbgnml (Balaur et al, 2020)
rnef2sbgn https://github.com/golovatenkop/rnef2sbgn
Seurat v4.0 https://satijalab.org/seurat/ (Hao et al, 2021)
DESeq2 10.18129/B9.bioc.DESeq2 (Love et al, 2014)
Viper v1.26.0 10.18129/B9.bioc.viper (Alvarez et al, 2016)
DoRothEA v1.4.1 10.18129/B9.bioc.dorothea (Garcia-Alonso et al, 2019)
CaSQ v0.9.11 Aghamiri et al (2020)
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Reagents and Tools table (continued)
Reagent/Resource Reference or Source Identifier or Catalog Number
CoV-HiPathia Rian et al (2021)
Datasets
IMEx Consortium COVID-19 dataset Perfetto et al (2020)
SIGNOR 2.0 COVID-19 dataset Licata et al (2020)
OmniPath T€urei et al (2021)
INDRA EMMAA Collection, accessed: 2020.12.01 https://emmaa.indra.bio/dashboard/covid19
RNA-Seq transcriptomic single-cell profiles https://eils-lung.cells.ucsc.edu
https://doi.org/10.6084/m9.figshare.11981034.v1 (Lukassen et al, 2020)
SARS-CoV-2-infected intestinal organoids Triana et al (2021) GSE156760
SARS-CoV-2-infected Calu-3 cells Blanco-Melo et al (2020) GSE147507
SARS-CoV-2 nasopharyngeal swabs Lieberman et al (2020) GSE152075
Methods and Protocols
Biocuration platforms
Individual diagrams were encoded in systems biology layout-aware
formats (see below) by biocurators using CellDesigner (Matsuoka
et al, 2014), Newt (https://newteditor.org), SBGN-ED (Czauderna
et al, 2010) and ySBGN (https://github.com/sbgn/ySBGN). This
community-based curation was coordinated by sharing curation
topics, e.g. relevant pathways or particular SARS-CoV-2 proteins
across the community to cover the available literature and identify
synergies. Curation guidelines (https://fairdomhub.org/documents/
661) were established to ensure proper representation and annota-
tion of the key features of the diagrams. Curation guidelines for logi-
cal models (Niarakis et al, 2020) were followed. Regular technical
reviews of the diagrams were performed following a previously
established checklist to harmonise their content. The diagrams are
stored and versioned in a GitLab repository (https://gitlab.lcsb.uni.
lu/covid/models). Individual diagrams are visualised in the
MINERVA Platform (Gawron et al, 2016). The entry-level view is
based on Fig 2.
Reactome (Jassal et al, 2020) biocuration efforts initially focused
on SARS-CoV-1 and its proteins, and their functions are extensively
documented in the experimental literature. Reactome curators were
assigned a subpathway from the viral life cycle, a host pathway or
potential therapeutics. Curators were supported by an editorial
manager and a dedicated SARS literature triage process. The result-
ing set of pathways for SARS-CoV-1 provided the basis for computa-
tional inference of the corresponding SARS-CoV-2 pathways based
on structural and functional homologies between the two viruses.
The computationally inferred SARS-CoV-2 infection pathway events
and entities were then reviewed and manually curated using
published SARS-CoV-2 experimental data. Reactome diagrams are
available via a dedicated pathway collection (https://reactome.org/
PathwayBrowser/#/R-HSA-9679506).
The WikiPathways (Slenter et al, 2018) diagrams were
constructed using PathVisio (Kutmon et al, 2015), with annotation
of pathway elements from the integrated BridgeDb identifier
mapping framework (van Iersel et al, 2010). All pathways are stored
in GPML format (Kutmon et al, 2015). The WikiPathways diagrams
are available via a dedicated pathway portal, grouping pathway
models specific to SARS-CoV-2, other coronaviruses and general
cellular processes relevant to the virus–host interactions (https://
www.wikipathways.org/index.php/Portal:COVID-19).
Layout-aware systems biology formats
The diagrams are available in SBML format (Keating et al, 2020),
allowing computational modelling of biological processes. SBML
stores visual information about encoded elements and reactions
using render (Bergmann et al, 2018) and layout (Gauges et al,
2015) packages. An early version of SBML adapted by CellDesigner
allows storing layout and rendering information. Systems Biology
Graphical Notation (SBGN) format is a graphical standard for visual
encodings of molecular entities and their interactions, implemented
using SBGNML (Bergmann et al, 2020) for encoding the layout of
SBGN maps and their annotations. Finally, GPML (Kutmon et al,
2015) is a structured XML format for computable representation of
biological knowledge used by the WikiPathways platform.
Interactions and interacting entities are annotated following a
uniform, persistent identification scheme, using either MIRIAM
Registry or Identifiers.org (Juty et al, 2012) and the guidelines for
annotations of computational models. Viral protein interactions are
explicitly annotated with their taxonomy identifiers to highlight find-
ings from strains other than SARS-CoV-2. Stable protein complexes
from SARS-CoV-2 and SARS are annotated using the Complex Portal.
Interaction databases
The biocuration process was supported by interaction and pathway
databases storing structured, annotated and curated information
about COVID-19 virus–host interactions. The IMEx Consortium
(Meldal et al, 2019) dataset (Perfetto et al, 2020) contains curated
Coronaviridae-related interaction data from reviewed manuscripts
and preprints, resulting in a dataset of roughly 7,300 interactions
extracted from over 250 publications, including data from SARS-
CoV-2, SARS, CoV, and other strains of Coronaviridae. The dataset
is updated with every release of IMEx data and is open access
(https://www.ebi.ac.uk/intact/resources/datasets#coronavirus). The
SIGNOR 2.0 (Licata et al, 2020) dataset contains manually anno-
tated and validated signalling interactions related to the host–virus
interaction, including cellular pathways modulated during SARS-
CoV-2 infection. The dataset was constructed from the literature on
causal interactions between SARS-CoV-2, SARS-COV-1, MERS proteins
and the human host and is openly available (https://signor.
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uniroma2.it/covid/). The Elsevier Pathway Collection (Daraselia
et al, 2004; Nesterova et al, 2020) COVID-19 dataset comprises
manually reconstructed and annotated pathway diagrams. State-
ments about molecular interactions are extracted into a knowledge
graph by a dedicated text mining technology adapted for extracting
facts about viral proteins and viruses from the literature. These
interactions were filtered for experimental evidence, used for path-
way reconstruction and made openly available (http://dx.doi.org/
10.17632/d55xn2c8mw.1). Information from OmniPath (T€urei et al,
2021) on existing interactions gathered from pathway and interac-
tion databases was used in a programmatic way to suggest cell-
specific interactions and cell–cell interactions specific to immune
reactions.
Text and figure mining
Text mining was performed on the CORD-19: COVID-19 Open
Research Dataset dataset (preprint: Lu Wang et al, 2020). INDRA
(Gyori et al, 2017), AILANI COVID-19 (https://ailani.ai) and BioKB
processed CORD-19 dataset (https://biokb.lcsb.uni.lu/topic/DOID:
0080599), with their results available programmatically via REST
API and SPARQL interfaces. An OpenNLP-based (https://opennlp.
apache.org/) text mining workflow using GNormPlus (Wei et al,
2015) was applied to the CORD-19 dataset and the collection of
MEDLINE abstracts associated with the genes in the SARS-CoV-2
PPI network (Gordon et al, 2020) using the Entrez GeneRIFs,
https://www.ncbi.nlm.nih.gov/gene/about-generif. (https://gitlab.
lcsb.uni.lu/covid/models/-/tree/master/Resources/Text%20mining).
Also, we used data from 221 CORD-19 dataset figures using a dedi-
cated Figure Mining Workflow (Hanspers et al, 2020), with results
available at https://gladstone-bioinformatics.shinyapps.io/shiny-cov
idpathways. Results of text mining were accessed by the curators in
the form of molecular interactions with references to the articles
and to sentences from which these interactions were derived. We
systematically aligned the C19DMap with assembled INDRA State-
ments, both to enrich and to extend the map (see “Crosstalk analysis”
below). The content of INDRA and AILANI COVID-19 was accessible
via interfaces that allow users to provide natural language queries,
such as “What are COVID-19 risk factors?” or “What are the interac-
tors of ACE2?”, facilitating extracting knowledge from the results of
text mining workflows. The results of the INDRA workflow were
visualised using the COVIDminer project (https://rupertoverall.net/
covidminer). Each extracted statement describes a directed interac-
tion between two gene products, small molecules or biological
processes. The causal network representing the COVIDminer data-
base is browsable through a web interface. The results of the
OpenNLP-based text mining workflow were imported into a BioKC
biocuration platform for structured processing and SBML export.
Crosstalk analysis
Crosstalk analysis was performed for the list of C19DMap diagrams
(Table EV1). The code is available at: https://gitlab.lcsb.uni.lu/
covid/models/-/tree/master/Resources/Crosstalks. Individual diagrams
were accessed via the API of the MINERVA Platform, WikiPathway
diagrams via the rWikipathways package (https://github.com/
wikipathways/rWikiPathways) and Reactome diagrams via the
Reactome API. Text mining interactions are from the INDRA EMMAA
Collection (https://emmaa.indra.bio/dashboard/covid19), dataset
timestamp: 2020-12-01-21-05-54. Verified molecular interactions for
quality control of the text mining data were obtained from Omni-
Path using the OmnipathR package (https://github.com/saezlab/
OmnipathR). We filtered text mining interactions of the EMMAA
dataset for “belief” of 0.8 or higher and retained those matching the
direction and interacting molecules to the OmniPath dataset. We call
this filtered group of interactions “EMMAA-OP interactions”.
Crosstalk between C19DMap diagrams was calculated based on
the HGNC identifiers of their elements. For simplification, all
elements of the same diagram were considered to be interacting with
each other. Three types of networks were constructed: existing cross-
talk, new crosstalk and new regulators. Diagram groups followed the
scheme in the list of C19DMap diagrams (Table EV1). The networks
were visualised using Cytoscape (Shannon et al, 2003). The colour
code is common for the networks: light green for nodes representing
a diagram or a diagram group, light blue for nodes having one or two
neighbours, yellow for nodes having three or four neighbours and
red for nodes with five or more neighbours. Diagram nodes have pre-
fixes indicating their provenance. Diagram groups have no prefixes,
as they combine diagrams across platforms. Existing crosstalk
between diagrams, or groups of diagrams, was calculated by identify-
ing shared HGNC identifiers linking diagrams or groups of diagrams.
To calculate new crosstalk between diagrams, we merged the
EMMAA-OP interactions with the network of existing crosstalk and
kept only those new interactions that link at least two upstream and
two downstream diagrams or diagram groups. To calculate new
upstream regulators of existing diagrams, we merged the EMMAA-OP
interactions with the network of existing crosstalk. We kept interac-
tions with source elements, not within existing diagrams, and target
elements in at least one existing diagram or diagram group.
Diagram interoperability and translation for
computational modelling
Bidirectional translation of curated diagrams between CellDesigner
and SBGNML formats is supported by the MINERVA Conversion
API https://minerva.pages.uni.lu/doc/api/15.1/converter/ (Hoksza
et al, 2020), and cd2sbgml converter https://github.com/sbgn/
cd2sbgnml (Balaur et al, 2020). The MINERVA Conversion API
supports bidirectional translation between CellDesigner, SBML and
GPML. Unidirectional translation from Reactome format to GPML is
supported by the Reactome-to-WikiPathways converter (Bohler
et al, 2016). Diagrams in the RNEF format of Elsevier Pathway
Studio were translated to SBGNML using a dedicated rnef2sbgn soft-
ware (https://github.com/golovatenkop/rnef2sbgn).
The C19DMap diagrams (Table EV1) in CellDesigner format were
translated using CaSQ (Aghamiri et al, 2020) into executable
Boolean networks. Conversion rules and logical formulae were
inferred according to the topology and the annotations of the
diagrams. SBML-qual files (Chaouiya et al, 2013) generated with
CaSQ (Aghamiri et al, 2020) retained their references, annotations
and layout of the original CellDesigner file. They can be used for in
silico simulations and analysis with CellCollective (Helikar et al,
2012), GINsim (Naldi et al, 2018a) or MaBoSS (Stoll et al, 2017).
CaSQ was adapted to produce SIF files necessary for HiPATHIA
(Hidalgo et al, 2017) and CARNIVAL (Liu et al, 2019) pipelines.
The C19DMap GitLab repository (https://gitlab.lcsb.uni.lu/covid/
models) was configured to translate stable versions of diagrams into
SBML qual and SIF files. The diagrams were translated to XGMML
using Cytoscape and GINSim.
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Calculation and visualisation of single-cell RNA-Seq
expression profiles
RNA-Seq transcriptomic single-cell profiles were calculated for (i)
non-infected airway cells (Lukassen et al, 2020; Data ref: Lukassen
et al, 2020) and (ii) SARS-CoV-2-infected intestinal organoids (Tri-
ana et al, 2021; Data ref: Triana et al, 2021). The Seurat package
(Hao et al, 2021) was used to calculate cell-specific transcriptional
profiles. For dataset (i), differential expression was calculated using
every cell type against remaining cell types and applying the
FindAllMarkers function of the Seurat package with min pct 0.25
and log fold change threshold 0.25. For dataset (ii), the cells were
classified into bystander or infected based on the absence or pres-
ence of SARS-CoV-2 mRNA measured by scRNAseq (Triana et al,
2021; Data ref: Triana et al, 2021). Differential expression was
calculated by contrasting the mock organoids with the bystander or
infected cells after 12 h or 24 h of treatment. Expression profiles for
the following cell types and conditions were selected for visualisa-
tion and enrichment analysis: for dataset (i), three types of secretory
cells; and for dataset (ii), infected and bystander immature entero-
cytes 24 h post-infection versus mock. The datasets were selected to
recapitulate the findings in the original papers and demonstrate the
capability of the C19DMap for cell-specific data interpretation.
Selected differentially expressed genes (DEGs) were prepared for
visualisation in the MINERVA Platform as follows. Differential
expression values were normalised to [1,1] range by dividing
by three and setting the outliers to their respective border
values. Expression values and their corresponding HGNC symbols
were used to create visual overlays in the C19DMap in the
MINERVA Platform (https://covid19map.elixir-luxembourg.org/
minerva/index.xhtml?id=covid19_map_17Jun21, “Overlays” tab).
On-the-fly exploration and enrichment analyses using the GSEA
plugin (Hoksza et al, 2019) are described in a dedicated guide
(https://covid.pages.uni.lu/minerva-guide/). Complete expression
analysis and transformation scripts are available in RMarkdown
files at https://gitlab.lcsb.uni.lu/covid/models/-/tree/master/Reso
urces/Omics%20analysis.
RNA-Seq-based analysis of transcription factor activity
RNA-Seq transcriptomic profiles of SARS-CoV-2 infection come from
SARS-CoV-2-infected Calu-3 cells measured 24 h after infection,
Gene Expression Omnibus reference GSE147507 (Blanco-Melo et al,
2020; Data ref: Blanco-Melo et al, 2020). Differential expression
analysis of the transcript abundances between conditions was
performed with DESeq2 (Love et al, 2014). The resulting t-values
from the differential expression analysis were used to estimate the
effect of SARS-CoV-2 at the transcription factor (TF) activity level.
This analysis was performed using the software Viper (Alvarez et al,
2016) algorithm coupled with TF–target interactions from DoRothEA
(Garcia-Alonso et al, 2019). DoRothEA TF–target interactions have
a confidence level based on the reliability of their source, which
ranges from A (most reliable) to E (least reliable). Here, interactions
with confidence levels A, B and C were selected. Activities of TFs
having at least five different targets were computed. The TFs
normalised enrichment score from the Viper output was mapped on
the “Interferon type I signalling pathway diagram” (https://
fairdomhub.org/models/713) of the C19DMap using the SIF files
generated by CaSQ. The resulting network was visualised using
Cytoscape (Shannon et al, 2003). Notebooks to reproduce the
results of this case study are available at https://github.com/
saezlab/Covid19.
RNA-seq-based analysis of pathway signalling
The CoV-HiPathia (Rian et al, 2021) web tool was used to calculate
the level of activity of the subpathways of the apoptosis diagram
(https://fairdomhub.org/models/712) from the C19DMap. RNA-Seq
transcriptomic profiles come from a public dataset of nasopharyngeal
swabs from 430 individuals with SARS-CoV-2 and 54 negative
controls, Gene Expression Omnibus reference GSE152075 (Lieberman
et al, 2020; Data ref: Lieberman et al, 2020). RNA-Seq gene expres-
sion data with the trimmed mean of M-values (TMM) normalisation
(Robinson et al, 2010) were rescaled to the range [0;1] for the calcu-
lation of the signal and normalised using quantile normalisation (Bol-
stad et al, 2003). Normalised gene expression values and the
experimental design (case/control sample names files) were uploaded
to CoV-Hipathia to calculate the level of activation of the signalling in
the selected diagram. A case/control contrast with a Wilcoxon test
was used to assess differences in signalling activity between the two
conditions. To reproduce the results, files with normalised gene
expression data and the experimental design can be generated
using the code https://gitlab.lcsb.uni.lu/covid/models/-/tree/master/
Resources/Hipathia/data_preprocessing. These files can then be used
in CoV-HiPathia at http://hipathia.babelomics.org/covid19/ under
the “Differential signalling” tab. Diagrams from the C19DMap can be
selected in the “Pathway source” section, under “Disease Maps
Community curated pathways”.
Data availability
COVID-19 Disease Map diagrams are available via:




Workflows, executable models and networkmodels are available via:
-the GitLab repository (https://gitlab.lcsb.uni.lu/covid/models).
-FAIRDOMHub (https://fairdomhub.org/projects/190).
Expanded View for this article is available online.
Acknowledgements
We would like to thank Andjela Tatarovic, architect, and Gina Crovetto, a
researcher in the field of cancer, for their help with the design of the top-level
view diagrams. We would like to acknowledge the Responsible and Reproducible
Research (R3) team of the Luxembourg Centre for Systems Biomedicine for
supporting the project and providing necessary communication and data shar-
ing resources. The work presented in this paper was carried out using the ELIXIR
Luxembourg tools and services. This study was supported by the Luxembourg
National Research Fund (FNR) COVID-19 Fast-Track grant programme, grant
COVID-19/2020-1/14715687/CovScreen (E. Glaab); European Commission,
INFORE grant H2020-ICT-825070 (A. Montagud, M. Ponce de Leon, M. Vazques
and A. Valencia); European Commission, PerMedCoE grant H2020-ICT-951773 (A.
Montagud, M. Ponce de Leon, M. Vazques and A. Valencia) the Federal Ministry
of Education and Research (BMBF, Germany) and the Baden-W€urttemberg
Ministry of Science, the Excellence Strategy of the German Federal and State
16 of 22 Molecular Systems Biology 17: e10387 | 2021 ª 2021 The Authors
Molecular Systems Biology Marek Ostaszewski et al
Governments (A. Renz); German Center for Infection Research (DZIF), grant no
8020708703 (A. Dr€ager); The Netherlands Organisation for Health Research and
Development (ZonMw), grant no 10430012010015, (M. Kutmon, S. Coort, F.
Ehrhart, N. Pham, E.L. Willighagen, C.T. Evelo); H2020 Marie Skłodowska-Curie
Actions, grant number 765274 (J. Scheel); National Institutes of Health, USA
(NIH), grant number U41 HG003751 (L.D. Stein). The development of Reactome
is supported by grants from the US National Institutes of Health (U41
HG003751) and the European Molecular Biology Laboratory.
Author contributions
MO, AN, AM and IK planned and coordinated the project. RP, AO-R, J-MR, RF, VO
and SM advised the project as domain experts. MO, AN, AM, IK, VS, SSA, MLA, EG,
AR, GF, CM, BB, GF, LCMG, JS, MH, SG, JS, HB, TC, FS, AM, MPL, AF, YH, NH, TGY,
AD, AR, MN, ZB, FM, DB, LF, MC, MR, VN, JV, LS, MW, EEA, JS, JZ, KO, JT, EK, GYS,
KH, MK, SC, LE, FE, DABR, DS, MM, NP, RH, BJ, LM, MO-M, ASR, KR, VS, RS, CS and
TV curated and reviewed the diagrams. MO, PG, ES, LH, VS, GW, AR, MG, SO, CG
and XH designed, developed and implemented key elements of the data sharing
and communication infrastructure. RW. Overall, DM, AB, BMG, JAB, CV, VG, MV,
PP, LL, MI, FS, AN, AY and AW designed and developed the contents of interac-
tion and pathway databases, and text mining platforms and their visualisation
and interoperability functionalities. AN, DT, AL, OB, SS, AV, ME, MP, KR, TH, BLP,
DM, AT, MO, BDM, SB, AD, AN, VN and LC developed format interoperability,
analysis and modelling workflows. CS, ED, TK, TF, FA, JSB, JH, OW, ELW, ARP, CTE,
MEG, LS, HH, PD’E, JS-R, JD, AV, HK, EB, CA, RB and RS defined the strategy and
scope of the project and revised its progress. MO, AN, AM and IK wrote the
manuscript. AO-R, IK and AM designed the overview figures. AW, PD’E, JSB and
LDS revised and contributed significantly to the structure of the manuscript. All
authors have revised, read and accepted the manuscript in its final form.
Conflict of interest
A. Niarakis collaborates with SANOFI-AVENTIS R&D via a public–private part-
nership grant (CIFRE contract, n° 2020/0766). D. Maier and A. Bauch are
employed at Biomax Informatics AG and will be affected by any effect of this
publication on the commercial version of the AILANI software. J.A. Bachman
and B. Gyori received consulting fees from Two Six Labs, LLC. T. Helikar has
served as a shareholder and/or has consulted for Discovery Collective, Inc. R.
Balling and R. Schneider are founders and shareholders of MEGENO S.A. and
ITTM S.A. J. Saez-Rodriguez receives funding from GSK and Sanofi and consul-
tant fees from Travere Therapeutics. The remaining authors have declared that
they have no Conflict of interest.
References
Aghamiri SS, Singh V, Naldi A, Helikar T, Soliman S, Niarakis A (2020)
Automated inference of Boolean models from molecular interaction maps
using CaSQ. Bioinforma Oxf Engl 36: 4473 – 4482
Alvarez MJ, Shen Y, Giorgi FM, Lachmann A, Ding BB, Ye BH, Califano A (2016)
Functional characterization of somatic mutations in cancer using
network-based inference of protein activity. Nat Genet 48: 838 – 847
Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q, Olejnik J,
Chandler KB, Xia C, Feldman J et al (2020) CD209L/L-SIGN and CD209/DC-
SIGN act as receptors for SARS-CoV-2 and are differentially expressed in
lung and kidney epithelial and endothelial cells. BioRxiv https://doi.org/10.
1101/2020.06.22.165803 [PREPRINT]
Angelini MM, Akhlaghpour M, Neuman BW, Buchmeier MJ (2013) Severe
acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6
induce double-membrane vesicles. Mbio 4: e00524-13
Attucks OC, Jasmer KJ, Hannink M, Kassis J, Zhong Z, Gupta S, Victory SF,
Guzel M, Polisetti DR, Andrews R et al (2014) Induction of heme
oxygenase I (HMOX1) by HPP-4382: a novel modulator of Bach1 activity.
PLoS One 9: e101044
Balaur I, Roy L, Mazein A, Karaca SG, Dogrusoz U, Barillot E, Zinovyev A
(2020) cd2sbgnml: bidirectional conversion between cell designer and
SBGN formats. Bioinform Oxf Engl 36: 2620 – 2622
Bao C, Liu X, Zhang H, Li Y, Liu J (2020) Coronavirus disease 2019 (COVID-19)
CT findings: A Systematic Review and Meta-analysis. J Am Coll Radiol JACR
17: 701 – 709
Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann H-H, Zhang Y,
Dorgham K, Philippot Q, Rosain J, Beziat V et al (2020) Auto-antibodies
against type I IFNs in patients with life-threatening COVID-19. Science
370: eabd4585
Batra N, De Souza C, Batra J, Raetz AG, Yu A-M (2020) The HMOX1 pathway
as a promising target for the treatment and prevention of SARS-CoV-2 of
2019 (COVID-19). Int J Mol Sci 21: 6412
Bauch A, Pellet J, Schleicher T, Yu X, Gelemanovic A, Cristella C, Fraaij PL,
Polasek O, Auffray C, Maier D et al (2020) Informing epidemic (research)
responses in a timely fashion by knowledge management - a Zika virus
use case. Biol Open 9: bio053934
Bello-Perez M, Sola I, Novoa B, Klionsky DJ, Falco A (2020) Canonical and
noncanonical autophagy as potential targets for COVID-19. Cells 9: 1619
Bergmann FT, Czauderna T, Dogrusoz U, Rougny A, Dr€ager A, Toure V, Mazein
A, Blinov ML, Luna A (2020) Systems biology graphical notation markup
language (SBGNML) version 0.3. J Integr Bioinforma 17: 20200016
Bergmann FT, Keating SM, Gauges R, Sahle S, Wengler K (2018) SBML level 3
package: Render, Version 1, Release 1. J Integr Bioinforma 15: 20170078
Berthelot J-M, Liote F (2020) COVID-19 as a STING disorder with delayed
over-secretion of interferon-beta. EBioMedicine 56: 102801
Blanco-Melo D, Nilsson-Payant BE, Liu W-C, Uhl S, Hoagland D, Møller R,
Jordan TX, Oishi K, Panis M, Sachs D et al (2020) imbalanced host response
to SARS-CoV-2 drives development of COVID-19. Cell 181: 1036 – 1045
Blanco-Melo D, Nilsson-Payant BE, Liu W-C, Uhl S, Hoagland D, Møller R,
Jordan TX, Oishi K, Panis M, Sachs D et al (2020) Gene Expression
Omnibus GSE147507 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE147507). [DATASET]
Bohler A, Wu G, Kutmon M, Pradhana LA, Coort SL, Hanspers K, Haw R, Pico
AR, Evelo CT (2016) Reactome from a WikiPathways perspective. PLoS
Comput Biol 12: e1004941
Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of
normalization methods for high density oligonucleotide array data based
on variance and bias. Bioinforma Oxf Engl 19: 185 – 193
Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, Correa Marrero M,
Polacco BJ, Melnyk JE, Ulferts S, Kaake RM et al (2020) The global
phosphorylation landscape of SARS-CoV-2 infection. Cell 182: 685 – 712
Chaouiya C, Berenguier D, Keating SM, Naldi A, van Iersel MP, Rodriguez N,
Dr€ager A, B€uchel F, Cokelaer T, Kowal B et al (2013) SBML qualitative
models: a model representation format and infrastructure to foster
interactions between qualitative modelling formalisms and tools. BMC
Syst Biol 7: 135
Chauhan D, Bartok E, Gaidt MM, Bock FJ, Herrmann J, Seeger JM, Broz P,
Beckmann R, Kashkar H, Tait SWG et al (2018) BAX/BAK-induced apoptosis
results in caspase-8-dependent IL-1b maturation in macrophages. Cell Rep
25: 2354 – 2368.e5
Chen G, Wu DI, Guo W, Cao Y, Huang DA, Wang H, Wang T, Zhang X, Chen
H, Yu H et al (2020a) Clinical and immunological features of severe and
moderate coronavirus disease 2019. J Clin Invest 130: 2620 – 2629
ª 2021 The Authors Molecular Systems Biology 17: e10387 | 2021 17 of 22
Marek Ostaszewski et al Molecular Systems Biology
Chen S, Jonas F, Shen C, Hilgenfeld R, Higenfeld R (2010) Liberation of SARS-
CoV main protease from the viral polyprotein: N-terminal autocleavage
does not depend on the mature dimerization mode. Protein Cell 1: 59 – 74
Chen X, Yang X, Zheng Y, Yang Y, Xing Y, Chen Z (2014) SARS coronavirus
papain-like protease inhibits the type I interferon signaling pathway
through interaction with the STING-TRAF3-TBK1 complex. Protein Cell 5:
369 – 381
Chen Y, Feng Z, Diao B, Wang R, Wang G, Wang C, Tan Y, Liu L, Wang C, Liu
Y et al (2020b) The novel severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) directly decimates human spleens and lymph nodes.
medRxiv https://doi.org/10.1101/2020.03.27.20045427 [PREPRINT]
Cheon H, Holvey-Bates EG, Schoggins JW, Forster S, Hertzog P, Imanaka N,
Rice CM, Jackson MW, Junk DJ, Stark GR (2013) IFNb-dependent increases
in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.
EMBO J 32: 2751 – 2763
Choi Y, Bowman JW, Jung JU (2018) Autophagy during viral infection – a
double-edged sword. Nat Rev Microbiol 16: 341 – 354
Chu H, Chan JF-W, Wang Y, Yuen TT-T, Chai Y, Hou Y, Shuai H, Yang D, Hu B,
Huang X et al (2020) Comparative replication and immune activation
profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study
with implications for the pathogenesis of COVID-19. Clin Infect Dis Publ
Infect Dis Soc Am 71: 1400 – 1409
Chu H, Zhou J, Wong BH-Y, Li C, Chan JF-W, Cheng Z-S, Yang D, Wang D, Lee
AC-Y, Li C et al (2016) Middle east respiratory syndrome coronavirus
efficiently infects human primary T lymphocytes and activates the
extrinsic and intrinsic apoptosis pathways. J Infect Dis 213: 904 – 914
Courtot M, Juty N, Kn€upfer C, Waltemath D, Zhukova A, Dr€ager A, Dumontier
M, Finney A, Golebiewski M, Hastings J et al (2011) Controlled
vocabularies and semantics in systems biology. Mol Syst Biol 7: 543
Czauderna T, Klukas C, Schreiber F (2010) Editing, validating and translating
of SBGN maps. Bioinforma Oxf Engl 26: 2340 – 2341
Daraselia N, Yuryev A, Egorov S, Novichkova S, Nikitin A, Mazo I (2004)
Extracting human protein interactions from MEDLINE using a full-
sentence parser. Bioinforma Oxf Engl 20: 604 – 611
De Meulder B, Lefaudeux D, Bansal AT, Mazein A, Chaiboonchoe A, Ahmed H,
Balaur I, Saqi M, Pellet J, Ballereau S et al (2018) A computational
framework for complex disease stratification from multiple large-scale
datasets. BMC Syst Biol 12: 60
DeDiego ML, Nieto-Torres JL, Jimenez-Guarde~no JM, Regla-Nava JA, Alvarez E,
Oliveros JC, Zhao J, Fett C, Perlman S, Enjuanes L (2011) Severe acute
respiratory syndrome coronavirus envelope protein regulates cell stress
response and apoptosis. PLoS Pathog 7: e1002315
Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe A,
Abbondanza D, Fleming SJ, Subramanian A, Montoro DT et al (2021)
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.
Nature 595: 107 – 113
Demir E, Cary MP, Paley S, Fukuda K, Lemer C, Vastrik I, Wu G, D’Eustachio P,
Schaefer C, Luciano J et al (2010) The BioPAX community standard for
pathway data sharing. Nat Biotechnol 28: 935 – 942
Devaraj SG, Wang N, Chen Z, Chen Z, Tseng M, Barretto N, Lin R, Peters CJ,
Tseng C-TK, Baker SC et al (2007) Regulation of IRF-3-dependent innate
immunity by the papain-like protease domain of the severe acute
respiratory syndrome coronavirus. J Biol Chem 282: 32208 – 32221
Diemer C, Schneider M, Sch€atzl HM, Gilch S (2010) Modulation of host cell death
by SARS coronavirus proteins. InMolecular biology of the SARS-coronavirus, Lal
SK (ed) pp 231 – 245. Berlin, Heidelberg: Springer Berlin Heidelberg
Dugourd A, Kuppe C, Sciacovelli M, Gjerga E, Gabor A, Emdal KB, Vieira V,
Bekker-Jensen DB, Kranz J, EricMJ B et al (2021) Causal integration of
multi-omics data with prior knowledge to generate mechanistic
hypotheses. Mol Syst Biol 17: e9730
Dugourd A, Saez-Rodriguez J (2019) Footprint-based functional analysis of
multiomic data. Curr Opin Syst Biol 15: 82 – 90
Fang R, Wang C, Jiang Q, Lv M, Gao P, Yu X, Mu P, Zhang R, Bi S, Feng J-M
et al (2017) (2017) NEMO-IKKb are essential for IRF3 and NF-jB activation
in the cGAS-STING pathway. J Immunol Baltim Md 199: 3222 – 3233
Fink K, Grandvaux N (2013) STAT2 and IRF9: Beyond ISGF3. JAK-STAT 2: e27521
Frieman M, Yount B, Heise M, Kopecky-Bromberg SA, Palese P, Baric RS
(2007) Severe acute respiratory syndrome coronavirus ORF6 antagonizes
STAT1 function by sequestering nuclear import factors on the rough
endoplasmic reticulum/Golgi membrane. J Virol 81: 9812 – 9824
Fukushi M, Yoshinaka Y, Matsuoka Y, Hatakeyama S, Ishizaka Y, Kirikae T,
Sasazuki T, Miyoshi-Akiyama T (2012) Monitoring of S protein maturation
in the endoplasmic reticulum by calnexin is important for the infectivity
of severe acute respiratory syndrome coronavirus. J Virol 86: 11745 – 11753
Fung TS, Liu DX (2019) Human coronavirus: host-pathogen interaction. Annu
Rev Microbiol 73: 529 – 557
Gagliardi I, Patella G, Michael A, Serra R, Provenzano M, Andreucci M (2020)
COVID-19 and the kidney: from epidemiology to clinical practice. J Clin
Med 9: 2506
Gao C, Zeng J, Jia N, Stavenhagen K, Matsumoto Y, Zhang H, Li J, Hume AJ,
M€uhlberger E, van Die I et al (2020) SARS-CoV-2 Spike Protein Interacts
with Multiple Innate Immune Receptors. BioRxiv https://doi.org/10.1101/
2020.07.29.227462 [PREPRINT]
Garcia-Alonso L, Holland CH, Ibrahim MM, Turei D, Saez-Rodriguez J (2019)
Benchmark and integration of resources for the estimation of human
transcription factor activities. Genome Res 29: 1363 – 1375
Gauges R, Rost U, Sahle S, Wengler K, Bergmann FT (2015) The Systems
Biology Markup Language (SBML) Level 3 Package: Layout, Version 1 Core.
J Integr Bioinforma 12: 267
Gawron P, Ostaszewski M, Satagopam V, Gebel S, Mazein A, Kuzma M,
Zorzan S, McGee F, Otjacques B, Balling R et al (2016) MINERVA-a
platform for visualization and curation of molecular interaction networks.
NPJ Syst Biol Appl 2: 16020
Ghaffarizadeh A, Heiland R, Friedman SH, Mumenthaler SM, Macklin P (2018)
PhysiCell: an open source physics-based cell simulator for 3-D
multicellular systems. PLoS Comput Biol 14: e1005991
Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J-C, Turner AJ, Raizada MK,
Grant MB, Oudit GY (2020) Angiotensin-Converting enzyme 2:
SARS-CoV-2 receptor and regulator of the renin-angiotensin system:
celebrating the 20th anniversary of the discovery of ACE2. Circ Res 126:
1456 –1474
Ghosh S, Dellibovi-Ragheb TA, Kerviel A, Pak E, Qiu Q, Fisher M, Takvorian PM,
Bleck C, Hsu VW, Fehr AR et al (2020) b-Coronaviruses use lysosomes for
egress instead of the biosynthetic secretory pathway. Cell 183: 1520– 1535
Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O’Meara MJ,
Rezelj VV, Guo JZ, Swaney DL et al (2020) A SARS-CoV-2 protein interaction
map reveals targets for drug repurposing. Nature 583: 459 –468
Gyori BM, Bachman JA, Subramanian K, Muhlich JL, Galescu L, Sorger PK
(2017) From word models to executable models of signaling networks
using automated assembly. Mol Syst Biol 13: 954
H€acker H, Karin M (2006) Regulation and function of IKK and IKK-related
kinases. Sci STKE Signal Transduct Knowl Environ 2006: re13
Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Pere H,
Charbit B, Bondet V, Chenevier-Gobeaux C et al (2020) Impaired type I
interferon activity and inflammatory responses in severe COVID-19
patients. Science 369: 718 – 724
18 of 22 Molecular Systems Biology 17: e10387 | 2021 ª 2021 The Authors
Molecular Systems Biology Marek Ostaszewski et al
Haga S, Yamamoto N, Nakai-Murakami C, Osawa Y, Tokunaga K, Sata T,
Yamamoto N, Sasazuki T, Ishizaka Y (2008) Modulation of TNF-alpha-
converting enzyme by the spike protein of SARS-CoV and ACE2 induces
TNF-alpha production and facilitates viral entry. Proc Natl Acad Sci USA
105: 7809 – 7814
Hanspers K, Riutta A, Summer-Kutmon M, Pico AR (2020) Pathway information
extracted from 25 years of pathway figures. Genome Biol 21:273
Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, Lee MJ, Wilk
AJ, Darby C, Zager M et al (2021) Integrated analysis of multimodal single-
cell data. Cell 184: 3573 – 3587
Hassan SM, Jawad MJ, Ahjel SW, Singh RB, Singh J, Awad SM, Hadi NR (2020)
The Nrf2 activator (DMF) and covid-19: is there a possible role? Med Arch
Sarajevo Bosnia Herzeg 74: 134 – 138
Hayek S, Pietrancosta N, Hovhannisyan AA, Alves de Sousa R, Bekaddour N,
Ermellino L, Tramontano E, Arnould S, Sardet C, Dairou J et al (2020)
Cerpegin-derived furo[3,4-c]pyridine-3,4(1H,5H)-diones enhance cellular
response to interferons by de novo pyrimidine biosynthesis inhibition. Eur
J Med Chem 186: 111855
Helikar T, Kowal B, McClenathan S, Bruckner M, Rowley T, Madrahimov A,
Wicks B, Shrestha M, Limbu K, Rogers JA (2012) The Cell Collective:
Toward an open and collaborative approach to systems biology. BMC Syst
Biol 6: 96
Hidalgo MR, Cubuk C, Amadoz A, Salavert F, Carbonell-Caballero J, Dopazo J
(2017) High throughput estimation of functional cell activities reveals
disease mechanisms and predicts relevant clinical outcomes. Oncotarget 8:
5160 – 5178
Hoffmann M, Kleine-Weber H, Pöhlmann S (2020a) A multibasic cleavage site
in the spike protein of SARS-CoV-2 is essential for infection of human lung
cells. Mol Cell 78: 779 – 784
Hoffmann M, Kleine-Weber H, Schroeder S, Kr€uger N, Herrler T, Erichsen S,
Schiergens TS, Herrler G, Wu N-H, Nitsche A et al (2020b) SARS-CoV-2 cell
entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven
protease inhibitor. Cell 181: 271 – 280
Hoksza D, Gawron P, Ostaszewski M, Smula E, Schneider R (2019) MINERVA
API and plugins: opening molecular network analysis and visualization to
the community. Bioinforma Oxf Engl 35: 4496 – 4498
Hoksza D, Gawron P, Ostaszewski M, Hasenauer J, Schneider R (2020) Closing
the gap between formats for storing layout information in systems
biology. Brief Bioinform 21: 1249 – 1260
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu YI, Zhang LI, Fan G, Xu J, Gu X et al
(2020) Clinical features of patients infected with 2019 novel coronavirus
in Wuhan, China. Lancet Lond Engl 395: 497 – 506
Hui KPY, Cheung M-C, Perera RAPM, Ng K-C, Bui CHT, Ho JCW, Ng MMT,
Kuok DIT, Shih KC, Tsao S-W et al (2020) Tropism, replication competence,
and innate immune responses of the coronavirus SARS-CoV-2 in human
respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro
cultures. Lancet Respir Med 8: 687 – 695
Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M (2020) The unique
characteristics of COVID-19 coagulopathy. Crit Care Lond Engl 24: 360
van Iersel MP, Pico AR, Kelder T, Gao J, Ho I, Hanspers K, Conklin BR, Evelo CT
(2010) The BridgeDb framework: standardized access to gene, protein and
metabolite identifier mapping services. BMC Bioinformatics 11: 5
Jassal B, Matthews L, Viteri G, Gong C, Lorente P, Fabregat A, Sidiropoulos K,
Cook J, Gillespie M, Haw R et al (2020) The Reactome Pathway
Knowledgebase. Nucleic Acids Res 48: D498 –D503
Juty N, Le Novere N, Laibe C (2012) Identifiers.org and MIRIAM Registry:
community resources to provide persistent identification. Nucleic Acids Res
40: D580 – 586
Kanzawa N, Nishigaki K, Hayashi T, Ishii Y, Furukawa S, Niiro A, Yasui F, Kohara
M, Morita K, Matsushima K et al (2006) Augmentation of chemokine
production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/
X4 proteins through NF-kappaB activation. FEBS Lett 580: 6807 – 6812
Keating SM, Waltemath D, König M, Zhang F, Dr€ager A, Chaouiya C,
Bergmann FT, Finney A, Gillespie CS, Helikar T et al (2020) SBML Level 3:
an extensible format for the exchange and reuse of biological models. Mol
Syst Biol 16: e9110
Kedia-Mehta N, Finlay DK (2019) Competition for nutrients and its role in
controlling immune responses. Nat Commun 10: 2123
Kesic MJ, Simmons SO, Bauer R, Jaspers I (2011) Nrf2 expression modifies
influenza A entry and replication in nasal epithelial cells. Free Radic Biol
Med 51: 444 – 453
Klok FA, Kruip M, van der Meer N, Arbous MS, Gommers D, Kant KM, Kaptein
F, van Paassen J, Stals M, Huisman MV et al (2020) Incidence of
thrombotic complications in critically ill ICU patients with COVID-19.
Thromb Res 191: 145 – 147
Kr€ahling V, Stein DA, Spiegel M, Weber F, M€uhlberger E (2009) Severe acute
respiratory syndrome coronavirus triggers apoptosis via protein kinase R
but is resistant to its antiviral activity. J Virol 83: 2298 – 2309
Kutmon M, van Iersel MP, Bohler A, Kelder T, Nunes N, Pico AR, Evelo CT
(2015) PathVisio 3: an extendable pathway analysis toolbox. PLoS Comput
Biol 11: e1004085
Lee JS, Shin E-C (2020) The type I interferon response in COVID-19:
implications for treatment. Nat Rev Immunol 20: 585 – 586
Letko M, Marzi A, Munster V (2020) Functional assessment of cell entry and
receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat
Microbiol 5: 562 – 569
Letort G, Montagud A, Stoll G, Heiland R, Barillot E, Macklin P, Zinovyev A,
Calzone L (2019) PhysiBoSS: a multi-scale agent-based modelling
framework integrating physical dimension and cell signalling. Bioinforma
Oxf Engl 35: 1188 – 1196
Li S, Zhang Y, Guan Z, Li H, Ye M, Chen X, Shen J, Zhou Y, Shi Z-L, Zhou P
et al (2020) SARS-CoV-2 triggers inflammatory responses and cell death
through caspase-8 activation. Signal Transduct Target Ther 5: 235
Li S-W, Wang C-Y, Jou Y-J, Huang S-H, Hsiao L-H, Wan L, Lin Y-J, Kung S-H,
Lin C-W (2016) SARS coronavirus papain-like protease inhibits the TLR7
signaling pathway through removing Lys63-linked polyubiquitination of
TRAF3 and TRAF6. Int J Mol Sci 17: 678
Liao Q-J, Ye L-B, Timani KA, Zeng Y-C, She Y-L, Ye L, Wu Z-H (2005) Activation
of NF-kappaB by the full-length nucleocapsid protein of the SARS
coronavirus. Acta Biochim Biophys Sin 37: 607 – 612
Licata L, Lo Surdo P, Iannuccelli M, Palma A, Micarelli E, Perfetto L, Peluso D,
Calderone A, Castagnoli L, Cesareni G (2020) SIGNOR 2.0, the SIGnaling
network open resource 2.0: 2019 update. Nucleic Acids Res 48: D504 –D510
Lieberman NAP, Peddu V, Xie H, Shrestha L, Huang M-L, Mears MC, Cajimat
MN, Bente DA, Shi P-Y, Bovier F et al (2020) Gene Expression Omnibus
GSE152075 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE152075). [DATASET]
Lieberman NAP, Peddu V, Xie H, Shrestha L, Huang M-L, Mears MC, Cajimat
MN, Bente DA, Shi P-Y, Bovier F et al (2020) In vivo antiviral host
transcriptional response to SARS-CoV-2 by viral load, sex, and age. PLoS
Biol 18: e3000849
Liu A, Trairatphisan P, Gjerga E, Didangelos A, Barratt J, Saez-Rodriguez J
(2019) From expression footprints to causal pathways: contextualizing
large signaling networks with CARNIVAL. NPJ Syst Biol Appl 5: 40
Liu M, Yang Y, Gu C, Yue Y, Wu KK, Wu J, Zhu Y (2007) Spike protein of SARS-
CoV stimulates cyclooxygenase-2 expression via both calcium-dependent
ª 2021 The Authors Molecular Systems Biology 17: e10387 | 2021 19 of 22
Marek Ostaszewski et al Molecular Systems Biology
and calcium-independent protein kinase C pathways. FASEB J Publ Fed Am
Soc Exp Biol 21: 1586 – 1596
Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol 15: 550
Lu Wang L, Lo K, Chandrasekhar Y, Reas R, Yang J, Eide D, Funk K, Kinney R,
Liu Z, Merrill W et al (2020) CORD-19: The Covid-19 Open Research
Dataset. ArXiv https://arxiv.org/abs/2004.10706v2 [PREPRINT]
Lubin JH, Zardecki C, Dolan EM, Lu C, Shen Z, Dutta S, Westbrook JD, Hudson
BP, Goodsell DS, Williams JK et al (2020) Evolution of the SARS-CoV-2
proteome in three dimensions (3D) during the first six months of the
COVID-19 pandemic. BioRxiv https://doi.org/10.1101/2020.12.01.406637
[PREPRINT]
Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, Ellingson MK, Mao
T, Oh JE, Israelow B et al (2020) Longitudinal analyses reveal
immunological misfiring in severe COVID-19. Nature 584: 463 – 469
Lukassen S, Chua RL, Trefzer T, Kahn NC, Schneider MA, Muley T, Winter H,
Meister M, Veith C, Boots AW et al (2020) Figshare 11981034
(https://doi.org/https://doi.org/10.6084/m9.figshare.11981034.v1). [DATASET]
Lukassen S, Chua RL, Trefzer T, Kahn NC, Schneider MA, Muley T, Winter H,
Meister M, Veith C, Boots AW et al (2020) SARS-CoV-2 receptor ACE2 and
TMPRSS2 are primarily expressed in bronchial transient secretory cells.
EMBO J 39: e105114
Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, Baxter-Stoltzfus A,
Laurence J (2020) Complement associated microvascular injury and
thrombosis in the pathogenesis of severe COVID-19 infection: A report of
five cases. Transl Res J Lab Clin Med 220: 1 – 13
Mantlo E, Bukreyeva N, Maruyama J, Paessler S, Huang C (2020) Antiviral activities
of type I interferons to SARS-CoV-2 infection. Antiviral Res 179: 104811
Mason RJ (2020) Pathogenesis of COVID-19 from a cell biology perspective.
Eur Respir J 55: 2000607
Matsuoka Y, Funahashi A, Ghosh S, Kitano H (2014) Modeling and simulation
using Cell Designer. Methods Mol Biol Clifton NJ 1164: 121 – 145
Mazein A, Ostaszewski M, Kuperstein I, Watterson S, Le Novere N, Lefaudeux
D, De Meulder B, Pellet J, Balaur I, Saqi M et al (2018) Systems medicine
disease maps: community-driven comprehensive representation of disease
mechanisms. NPJ Syst Biol Appl 4: 21
McFadyen JD, Stevens H, Peter K (2020) The emerging threat of (Micro)Thrombosis
in COVID-19 and Its therapeutic implications. Circ Res 127: 571– 587
Meldal BHM, Bye-A-Jee H, Gajdos L, Hammerova Z, Horackova A, Melicher F,
Perfetto L, Pokorny D, Lopez MR, T€urkova A et al (2019) Complex Portal
2018: extended content and enhanced visualization tools for
macromolecular complexes. Nucleic Acids Res 47: D550 –D558
Mesev EV, LeDesma RA, Ploss A (2019) Decoding type I and III interferon
signalling during viral infection. Nat Microbiol 4: 914 – 924
Messina F, Giombini E, Agrati C, Vairo F, Ascoli Bartoli T, Al Moghazi S,
Piacentini M, Locatelli F, Kobinger G, Maeurer M et al (2020) COVID-19:
viral-host interactome analyzed by network based-approach model to
study pathogenesis of SARS-CoV-2 infection. J Transl Med 18: 233
Miao G, Zhao H, Li Y, Ji M, Chen Y, Shi Y, Bi Y, Wang P, Zhang H (2020)
ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated
assembly of the SNARE complex required for autolysosome formation. Dev
Cell 56: 427 – 442
Mogensen TH (2009) Pathogen recognition and inflammatory signaling in
innate immune defenses. Clin Microbiol Rev 22: 240 – 273
Murakami Y, Hoshi M, Imamura Y, Arioka Y, Yamamoto Y, Saito K (2013)
Remarkable role of indoleamine 2,3-dioxygenase and tryptophan
metabolites in infectious diseases: potential role in macrophage-mediated
inflammatory diseases. Mediators Inflamm 2013: 391984
Naithani S, Gupta P, Preece J, Garg P, Fraser V, Padgitt-Cobb LK, Martin M,
Vining K, Jaiswal P (2019) Involving community in genes and pathway
curation. Database 2019: bay146
Nakagawa K, Lokugamage KG, Makino S (2016) Viral and cellular mRNA
translation in coronavirus-infected cells. Adv Virus Res 96: 165 – 192
Naldi A, Hernandez C, Abou-Jaoude W, Monteiro PT, Chaouiya C, Thieffry D
(2018a) Logical modeling and analysis of cellular regulatory networks with
GINsim 3.0. Front Physiol 9: 646
Naldi A, Hernandez C, Levy N, Stoll G, Monteiro PT, Chaouiya C, Helikar T,
Zinovyev A, Calzone L, Cohen-Boulakia S et al (2018b) The CoLoMoTo
interactive notebook: accessible and reproducible computational analyses
for qualitative biological networks. Front Physiol 9: 680
Nesterova AP, Klimov EA, Zharkova M, Sozin S, Sobolev V, Ivanikova NV,
Shkrob M, Yuryev A (2020) Guide and legend. In Disease Pathways, pp
xxi – xxviii. Cambridge, MA: Elsevier
Niarakis A, Kuiper M, Ostaszewski M, Malik Sheriff RS, Casals-Casas C,
Thieffry D, Freeman TC, Thomas P, Toure V, No€el V et al (2020) Setting the
basis of best practices and standards for curation and annotation of
logical models in biology-highlights of the [BC]2 2019 CoLoMoTo/SysMod
Workshop. Brief Bioinform 22: 1848 – 1859.
Novere NL, Hucka M, Mi H, Moodie S, Schreiber F, Sorokin A, Demir E,
Wegner K, Aladjem MI, Wimalaratne SM et al (2009) The systems biology
graphical notation. Nat Biotechnol 27: 735 – 741
Orchard S, Kerrien S, Abbani S, Aranda B, Bhate J, Bidwell S, Bridge A, Briganti
L, Brinkman FSL, Brinkman F et al (2012) Protein interaction data
curation: the International Molecular Exchange (IMEx) consortium. Nat
Methods 9: 345 – 350
Osborne JM, Fletcher AG, Pitt-Francis JM, Maini PK, Gavaghan DJ (2017)
Comparing individual-based approaches to modelling the self-
organization of multicellular tissues. PLoS Comput Biol 13: e1005387
Ostaszewski M, Mazein A, Gillespie ME, Kuperstein I, Niarakis A, Hermjakob
H, Pico AR, Willighagen EL, Evelo CT, Hasenauer J et al (2020) COVID-19
Disease Map, building a computational repository of SARS-CoV-2 virus-
host interaction mechanisms. Sci Data 7: 136
Park A, Iwasaki A (2020) Type I and type III interferons-induction, signaling,
evasion, and application to combat COVID-19. Cell Host Microbe 27:
870 – 878
Perfetto L, Pastrello C, Del-Toro N, Duesbury M, Iannuccelli M, Kotlyar M,
Licata L, Meldal B, Panneerselvam K, Panni S et al (2020) The IMEx
coronavirus interactome: an evolving map of Coronaviridae-host
molecular interactions. Database (Oxford) 2020: baaa096
Pillich RT, Chen J, Rynkov V, Welker D, Pratt D (2017) NDEx: a community
resource for sharing and publishing of biological networks. Methods Mol
Biol Clifton NJ 1558: 271 – 301
Rao M, Dodoo E, Zumla A, Maeurer M (2019) Immunometabolism and
pulmonary infections: implications for protective immune responses and
host-directed therapies. Front Microbiol 10: 962
Renz A, Widerspick L, Dr€ager A (2020) FBA reveals guanylate kinase as a
potential target for antiviral therapies against SARS-CoV-2. Bioinforma Oxf
Engl 36: i813 – i821
Rian K, Esteban-Medina M, Hidalgo MR, Çubuk C, Falco MM, Loucera C,
Gunyel D, Ostaszewski M, Pe~na-Chilet M, Dopazo J (2021) Mechanistic
modeling of the SARS-CoV-2 disease map. BioData Min 14: 5
Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package
for differential expression analysis of digital gene expression data.
Bioinforma Oxf Engl 26: 139 – 140
Rodchenkov I, Babur O, Luna A, Aksoy BA, Wong JV, Fong D, Franz M, Siper
MC, Cheung M, Wrana M et al (2020) Pathway Commons 2019 Update:
20 of 22 Molecular Systems Biology 17: e10387 | 2021 ª 2021 The Authors
Molecular Systems Biology Marek Ostaszewski et al
integration, analysis and exploration of pathway data. Nucleic Acids Res
48: D489 –D497
Rubio D, Xu R-H, Remakus S, Krouse TE, Truckenmiller ME, Thapa RJ,
Balachandran S, Alcamı A, Norbury CC, Sigal LJ (2013) Crosstalk between
the type 1 interferon and nuclear factor kappa B pathways confers
resistance to a lethal virus infection. Cell Host Microbe 13: 701 – 710
Sa Ribero M, Jouvenet N, Dreux M, Nisole S (2020) Interplay between SARS-
CoV-2 and the type I interferon response. PLoS Pathog 16: e1008737
Salavert F, Hidago MR, Amadoz A, Çubuk C, Medina I, Crespo D, Carbonell-
Caballero J, Dopazo J (2016) Actionable pathways: interactive discovery of
therapeutic targets using signaling pathway models. Nucleic Acids Res 44:
W212 – 216
Satagopam V, Gu W, Eifes S, Gawron P, Ostaszewski M, Gebel S, Barbosa-
Silva A, Balling R, Schneider R (2016) Integration and visualization of
translational medicine data for better understanding of human diseases.
Big Data 4: 97 – 108
Seo GJ, Kim C, Shin W-J, Sklan EH, Eoh H, Jung JU (2018) TRIM56-mediated
monoubiquitination of cGAS for cytosolic DNA sensing. Nat Commun 9: 613
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N,
Schwikowski B, Ideker T (2003) Cytoscape: a software environment for
integrated models of biomolecular interaction networks. Genome Res 13:
2498 – 2504
Slayden RA, Jackson M, Zucker J, Ramirez MV, Dawson CC, Crew R, Sampson
NS, Thomas ST, Jamshidi N, Sisk P et al (2013) Updating and curating
metabolic pathways of TB. Tuberc Edinb Scotl 93: 47 – 59
Slenter DN, Kutmon M, Hanspers K, Riutta A, Windsor J, Nunes N, Melius J,
Cirillo E, Coort SL, Digles D et al (2018) WikiPathways: a multifaceted
pathway database bridging metabolomics to other omics research. Nucleic
Acids Res 46: D661 –D667
Smith JA (2018) Regulation of cytokine production by the unfolded protein
response; implications for infection and autoimmunity. Front Immunol 9: 422
Stoll G, Caron B, Viara E, Dugourd A, Zinovyev A, Naldi A, Kroemer G, Barillot
E, Calzone L (2017) MaBoSS 2.0: an environment for stochastic Boolean
modeling. Bioinforma Oxf Engl 33: 2226 – 2228
Su S, Jiang S (2020) A suspicious role of interferon in the pathogenesis of SARS-
CoV-2 by enhancing expression of ACE2. Signal Transduct Target Ther 5: 71
Su Y, Chen D, Lausted C, Yuan D, Choi J, Dai C, Voillet V, Scherler K, Troisch P,
Duvvuri VR et al (2020) Multiomic immunophenotyping of COVID-19
patients reveals early infection trajectories immunology. bioRxiv https://
doi.org/10.1101/2020.07.27.224063 [PREPRINT]
Sureda A, Alizadeh J, Nabavi SF, Berindan-Neagoe I, Cismaru CA, Jeandet P,
Łos MJ, Clementi E, Nabavi SM, Ghavami S (2020) Endoplasmic reticulum
as a potential therapeutic target for covid-19 infection management? Eur
J Pharmacol 882: 173288
Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation.
Cell 140: 805 – 820
Thoms M, Buschauer R, Ameismeier M, Koepke L, Denk T, Hirschenberger M,
Kratzat H, Hayn M, Mackens-Kiani T, Cheng J et al (2020) Structural basis
for translational shutdown and immune evasion by the Nsp1 protein of
SARS-CoV-2. Science 369: 1249– 1255
Triana S, Metz-Zumaran C, Ramirez C, Kee C, Doldan P, Shahraz M,
Schraivogel D, Gschwind AR, Sharma AK, Steinmetz LM et al (2021) Single-
cell analyses reveal SARS-CoV-2 interference with intrinsic immune
response in the human gut. Mol Syst Biol 17: e10232
Triana S, Metz-Zumaran C, Ramirez C, Kee C, Doldan P, Shahraz M,
Schraivogel D, Gschwind AR, Sharma AK, Steinmetz LM et al (2021) Gene
Expression Omnibus GSE156760 (https://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE156760). [DATASET]
T€urei D, Korcsmaros T, Saez-Rodriguez J (2016) OmniPath: guidelines and
gateway for literature-curated signaling pathway resources. Nat Methods
13: 966 – 967
T€urei D, Valdeolivas A, Gul L, Palacio-Escat N, Klein M, Ivanova O, Ölbei M,
Gabor A, Theis F, Modos D et al (2021) Integrated intra- and intercellular
signaling knowledge for multicellular omics analysis. Mol Syst Biol 17
Urwyler P, Moser S, Charitos P, Heijnen IAFM, Rudin M, Sommer G, Giannetti
BM, Bassetti S, Sendi P, Trendelenburg M et al (2020) Treatment of
COVID-19 with conestat alfa, a regulator of the complement, contact
activation and kallikrein-kinin system. Front Immunol 11: 2072
V’kovski P, Gerber M, Kelly J, Pfaender S, Ebert N, Braga Lagache S, Simillion
C, Portmann J, Stalder H, Gaschen V et al (2019) Determination of host
proteins composing the microenvironment of coronavirus replicase
complexes by proximity-labeling. eLife 8: e42037
Valencia I, Peiro C, Lorenzo O, Sanchez-Ferrer CF, Eckel J, Romacho T (2020)
DPP4 and ACE2 in diabetes and COVID-19: therapeutic targets for
cardiovascular complications? Front Pharmacol 11: 1161
van den Berg DF, Te Velde AA (2020) Severe COVID-19: NLRP3 inflammasome
dysregulated. Front Immunol 11: 1580
Wang Y, An G, Becker A, Cockrell C, Collier N, Craig M, Davis CL, Faeder J,
Versypt ANF, Gianlupi JF et al (2020) Iterative community-driven
development of a SARS-CoV-2 tissue simulator. BioRxiv https://doi.org/10.
1101/2020.04.02.019075 [PREPRINT]
Wei C-H, Kao H-Y, Lu Z (2015) GNormPlus: an integrative approach for tagging
genes, gene families, and protein domains. BioMed Res Int 2015: 1 – 7
Wilkinson MD, Dumontier M, IjJ A, Appleton G, Axton M, Baak A, Blomberg N,
Boiten J-W, da Silva Santos LB, Bourne PE et al (2016) The FAIR Guiding
Principles for scientific data management and stewardship. Sci Data 3: 160018
Wimalaratne SM, Juty N, Kunze J, Janee G, McMurry JA, Beard N, Jimenez R,
Grethe JS, Hermjakob H, Martone ME et al (2018) Uniform resolution of
compact identifiers for biomedical data. Sci Data 5: 180029
Wolstencroft K, Krebs O, Snoep JL, Stanford NJ, Bacall F, Golebiewski M,
Kuzyakiv R, Nguyen Q, Owen S, Soiland-Reyes S et al (2017) FAIRDOMHub:
a repository and collaboration environment for sharing systems biology
research. Nucleic Acids Res 45: D404 –D407
Wong HH, Fung TS, Fang S, Huang M, Le MT, Liu DX (2018) Accessory
proteins 8b and 8ab of severe acute respiratory syndrome coronavirus
suppress the interferon signaling pathway by mediating ubiquitin-
dependent rapid degradation of interferon regulatory factor 3. Virology
515: 165 – 175
Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, Ying T, Liu S, Shi Z, Jiang S et al
(2020) Fusion mechanism of 2019-nCoV and fusion inhibitors targeting
HR1 domain in spike protein. Cell Mol Immunol 17: 765 – 767
Xiong R, Zhang L, Li S, Sun Y, Ding M, Wang Y, Zhao Y, Wu Y, Shang W, Jiang
X et al (2020) Novel and potent inhibitors targeting DHODH are broad-
spectrum antivirals against RNA viruses including newly-emerged
coronavirus SARS-CoV-2. Protein Cell 11: 723 – 739
Yang N, Shen H-M (2020) Targeting the endocytic pathway and autophagy
process as a novel therapeutic strategy in COVID-19. Int J Biol Sci 16:
1724 – 1731
Zhang H, Tu J, Cao C, Yang T, Gao L (2020) Proteasome activator
PA28c-dependent degradation of coronavirus disease (COVID-
19) nucleocapsid protein. Biochem Biophys Res Commun 529: 251 –
256
Zhang X, Ding M, Zhu P, Huang H, Zhuang Q, Shen J, Cai Y, Zhao M, He Q
(2019) New insights into the Nrf-2/HO-1 signaling axis and its
application in pediatric respiratory diseases. Oxid Med Cell Longev 2019:
3214196
ª 2021 The Authors Molecular Systems Biology 17: e10387 | 2021 21 of 22
Marek Ostaszewski et al Molecular Systems Biology
Zheng Y, Zhuang M-W, Han L, Zhang J, Nan M-L, Zhan P, Kang D, Liu X, Gao
C, Wang P-H (2020) Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) membrane (M) protein inhibits type I and III interferon
production by targeting RIG-I/MDA-5 signaling. Signal Transduct Target
Ther 5: 299
Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, Cao Y,
Yousif AS, Bals J, Hauser BM et al (2020) SARS-CoV-2 receptor ACE2 is an
interferon-stimulated gene in human airway epithelial cells and is
detected in specific cell subsets across tissues. Cell 181: 1016 – 1035
Zipeto D, da Palmeira JF, Arga~naraz GA, Arga~naraz ER (2020) ACE2/ADAM17/
TMPRSS2 interplay may be the main risk factor for COVID-19. Front
Immunol 11: 576745
License: This is an open access article under the
terms of the Creative Commons Attribution License,
which permits use, distribution and reproduction in
any medium, provided the original work is properly
cited.
List of affiliations
Marek Ostaszewski1,*; Anna Niarakis2,3; Alexander Mazein1; Inna Kuperstein4,5,6; Robert Phair7; Aurelio Orta-Resendiz8,9; Vidisha Singh2; Sara Sadat Aghamiri10; Marcio Luis
Acencio1; Enrico Glaab1; Andreas Ruepp11; Gisela Fobo11; Corinna Montrone11; Barbara Brauner11; Goar Frishman11; Luis Cristobal Monraz Gomez4,5,6; Julia Somers12; Matti Hoch13;
Shailendra Kumar Gupta13; Julia Scheel13; Hanna Borlinghaus14; Tobias Czauderna15; Falk Schreiber14,15; Arnau Montagud16; Miguel Ponce de Leon16; Akira Funahashi17; Yusuke
Hiki17; Noriko Hiroi18; Takahiro G Yamada17; Andreas Dr€ager19,20,21; Alina Renz19,20; Muhammad Naveez13,22; Zsolt Bocskei23; Francesco Messina24,25; Daniela Börnigen26; Liam
Fergusson27; Marta Conti28; Marius Rameil28; Vanessa Nakonecnij28; Jakob Vanhoefer28; Leonard Schmiester28,29; Muying Wang30; Emily E Ackerman30; Jason E Shoemaker30,31;
Jeremy Zucker32; Kristie Oxford32; Jeremy Teuton32; Ebru Kocakaya33; Gökçe Yagmur Summak33; Kristina Hanspers34; Martina Kutmon35,36; Susan Coort35; Lars Eijssen35,37; Friederike
Ehrhart35,37; Devasahayam Arokia Balaya Rex38; Denise Slenter35; Marvin Martens35; Nhung Pham35; Robin Haw39; Bijay Jassal39; Lisa Matthews40; Marija Orlic-Milacic39; Andrea
Senff Ribeiro39,41; Karen Rothfels39; Veronica Shamovsky40; Ralf Stephan39; Cristoffer Sevilla42; Thawfeek Varusai42; Jean-Marie Ravel43,44; Rupsha Fraser45; Vera Ortseifen46; Silvia
Marchesi47; Piotr Gawron1,48; Ewa Smula1; Laurent Heirendt1; Venkata Satagopam1; Guanming Wu49; Anders Riutta34; Martin Golebiewski50; Stuart Owen51; Carole Goble51;
Xiaoming Hu50; Rupert W Overall52,53,54; Dieter Maier55; Angela Bauch55; Benjamin M Gyori56; John A Bachman56; Carlos Vega1; Valentin Groues1; Miguel Vazquez16; Pablo Porras42;
Luana Licata57; Marta Iannuccelli57; Francesca Sacco57; Anastasia Nesterova58; Anton Yuryev58; Anita de Waard59; Denes Turei60; Augustin Luna61,62; Ozgun Babur63; Sylvain
Soliman3; Alberto Valdeolivas60; Marina Esteban-Medina64,65; Maria Pe~na-Chilet64,65,66; Kinza Rian64,65; Tomas Helikar67; Bhanwar Lal Puniya67; Dezso Modos68,69; Agatha
Treveil68,69; Marton Olbei68,69; Bertrand De Meulder70; Stephane Ballereau71; Aurelien Dugourd60,72; Aurelien Naldi3; Vincent No€el4,5,6; Laurence Calzone4,5,6; Chris Sander61,62; Emek
Demir12; Tamas Korcsmaros68,69; Tom C Freeman73; Franck Auge23; Jacques S Beckmann74; Jan Hasenauer75,76; Olaf Wolkenhauer13; Egon L Wilighagen35; Alexander R Pico34; Chris T
Evelo35,36; Marc E Gillespie39,77; Lincoln D Stein39,78; Henning Hermjakob42; Peter D’Eustachio40; Julio Saez-Rodriguez60; Joaquin Dopazo64,65,66,79; Alfonso Valencia16,80; Hiroaki
Kitano81,82; Emmanuel Barillot4,5,6; Charles Auffray71; Rudi Balling1; Reinhard Schneider1; the COVID-19 Disease Map Community,†
1Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg. 2Universite Paris-Saclay, Laboratoire Europeen de Recherche pour la
Polyarthrite rhumato€ıde - Genhotel, Univ Evry, Evry, France. 3Lifeware Group, Inria Saclay-Ile de France, Palaiseau, France. 4Institut Curie, PSL Research University, Paris, France.
5INSERM, Paris, France. 6MINES ParisTech, PSL Research University, Paris, France. 7Integrative Bioinformatics, Inc., Mountain View, CA, USA. 8Institut Pasteur, Universite de Paris,
Unite HIV, Inflammation et Persistance, Paris, France. 9Bio Sorbonne Paris Cite, Universite de Paris, Paris, France. 10Inserm- Institut national de la sante et de la recherche medicale,
Paris, France. 11Institute of Experimental Genetics (IEG), Helmholtz ZentrumM€unchen-German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
12Department of Molecular and Medical Genetics, Oregon Health & Sciences University, Portland, OR, USA. 13Department of Systems Biology and Bioinformatics, University of
Rostock, Rostock, Germany. 14Department of Computer and Information Science, University of Konstanz, Konstanz, Germany. 15Faculty of Information Technology, Department of
Human-Centred Computing, Monash University, Clayton, Vic., Australia. 16Barcelona Supercomputing Center (BSC), Barcelona, Spain. 17Department of Biosciences and Informatics,
Keio University, Yokohama, Japan. 18Graduate School of Media and Governance, Research Institute at SFC, Keio University, Kanagawa, Japan. 19Computational Systems Biology of
Infections and Antimicrobial-Resistant Pathogens, Institute for Bioinformatics andMedical Informatics (IBMI), University of T€ubingen, T€ubingen, Germany. 20Department of
Computer Science, University of T€ubingen, T€ubingen, Germany. 21German Center for Infection Research (DZIF), partner site, T€ubingen, Germany. 22Institute of Applied Computer
Systems, Riga Technical University, Riga, Latvia. 23Sanofi R&D, Translational Sciences, Chilly-Mazarin, France. 24Dipartimento di Epidemiologia Ricerca Pre-Clinica e Diagnostica
Avanzata, National Institute for Infectious Diseases ’Lazzaro Spallanzani’ I.R.C.C.S., Rome, Italy. 25COVID-19 INMI Network Medicine for IDs Study Group, National Institute for
Infectious Diseases ’Lazzaro Spallanzani’ I.R.C.C.S, Rome, Italy. 26Bioinformatics Core Facility, Universit€atsklinikum Hamburg-Eppendorf, Hamburg, Germany. 27Royal (Dick) School
of Veterinary Medicine, The University of Edinburgh, Edinburgh, UK. 28Faculty of Mathematics and Natural Sciences, University of Bonn, Bonn, Germany. 29Center for Mathematics,
Chair of Mathematical Modeling of Biological Systems, Technische Universit€at M€unchen, Garching, Germany. 30Department of Chemical and Petroleum Engineering, University of
Pittsburgh, Pittsburgh, PA, USA. 31Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA. 32Pacific Northwest National Laboratory,
Richland, WA, USA. 33Stem Cell Institute, Ankara University, Ankara, Turkey. 34Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA, USA.
35Department of Bioinformatics - BiGCaT, NUTRIM, Maastricht University, Maastricht, The Netherlands. 36Maastricht Centre for Systems Biology (MaCSBio), Maastricht University,
Maastricht, The Netherlands. 37Maastricht University Medical Centre, Maastricht, The Netherlands. 38Center for Systems Biology and Molecular Medicine, Yenepoya (Deemed to be
University), Mangalore, India. 39MaRS Centre, Ontario Institute for Cancer Research, Toronto, ON, Canada. 40NYU Grossman School of Medicine, New York, NY, USA. 41Universidade
Federal do Parana, Curitiba, Brasil. 42European Bioinformatics Institute (EMBL-EBI), EuropeanMolecular Biology Laboratory, Hinxton, Cambridgeshire, UK. 43INSERM UMR_S 1256,
Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, University of Lorraine, Nancy, France. 44Laboratoire de genetique medicale, CHRU
Nancy, Nancy, France. 45Queen’s Medical Research Institute, The University of Edinburgh, Edinburgh, UK. 46Senior Research Group in Genome Research of Industrial
Microorganisms, Center for Biotechnology, Bielefeld University, Bielefeld, Germany. 47Department of Surgical Science, Uppsala University, Uppsala, Sweden. 48Institute of
Computing Science, Poznan University of Technology, Poznan, Poland. 49Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University,
Portland, OR, USA. 50Heidelberg Institute for Theoretical Studies (HITS), Heidelberg, Germany. 51Department of Computer Science, The University of Manchester, Manchester, UK.
52German Center for Neurodegenerative Diseases (DZNE) Dresden, Dresden, Germany. 53Center for Regenerative Therapies Dresden (CRTD), Technische Universit€at Dresden,
Dresden, Germany. 54Institute for Biology, Humboldt University of Berlin, Berlin, Germany. 55Biomax Informatics AG, Planegg, Germany. 56Harvard Medical School, Laboratory of
Systems Pharmacology, Boston, MA, USA. 57Department of Biology, University of Rome Tor Vergata, Rome, Italy. 58Elsevier, Philadelphia, PA, USA. 59Research Collaborations Unit,
Elsevier, Jericho, VT, USA. 60Institute for Computational Biomedicine, Heidelberg University, Heidelberg, Germany. 61cBio Center, Divisions of Biostatistics and Computational
Biology, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA. 62Department of Cell Biology, Harvard Medical School, Boston, MA, USA. 63Computer Science
Department, University of Massachusetts Boston, Boston, MA, USA. 64Clinical Bioinformatics Area, Fundacion Progreso y Salud (FPS), Hospital Virgen del Rocio, Sevilla, Spain.
65Computational Systems Medicine Group, Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocio, Sevilla, Spain. 66Bioinformatics in Rare Diseases (BiER), Centro de
Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocıo, Sevilla, Spain. 67Department of Biochemistry, University of Nebraska-Lincoln,
Lincoln, NE, USA. 68Quadram Institute Bioscience, Norwich, UK. 69Earlham Institute, Norwich, UK. 70European Institute for Systems Biology andMedicine (EISBM), Vourles, France.
71Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. 72Institute of Experimental Medicine and Systems Biology, Faculty of Medicine, RWTH, Aachen
University, Aachen, Germany. 73The Roslin Institute, University of Edinburgh, Edinburgh, UK. 74University of Lausanne, Lausanne, Switzerland. 75Helmholtz ZentrumM€unchen –
German Research Center for Environmental Health, Institute of Computational Biology, Neuherberg, Germany. 76Interdisciplinary Research Unit Mathematics and Life Sciences,
University of Bonn, Bonn, Germany. 77St. John’s University College of Pharmacy and Health Sciences, Queens, NY, USA. 78Department of Molecular Genetics, University of Toronto,
Toronto, ON, Canada. 79FPS/ELIXIR-es, Hospital Virgen del Rocıo, Sevilla, Spain. 80Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. 81Systems Biology
Institute, Tokyo, Japan. 82Okinawa Institute of Science and Technology Graduate School, Okinawa, Japan.
22 of 22 Molecular Systems Biology 17: e10387 | 2021 ª 2021 The Authors
Molecular Systems Biology Marek Ostaszewski et al
